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Abstract
THE ROLE OF OPSONIN-INDEPENDENT BACTERIAL ADHERENCE IN THE 
PATHOGENESIS OF LEGIONNAIRES' DISEASE.
by
Frank C. Gibson III 
University of New Hampshire, May, 1994.
Legionella pneumopNIa is a facultative intracellular bacterial 
pathogen which initiates infection of the human host by adhering to 
macrophages in the alveoli of the lung following which internalization and 
intracellular multiplication occurs. In this study a novel mechanism of 
opsonin-independent attachment for this organism to host cells was 
identified. L. pneumophila serogroup 1, strain Nottingham N7, and U-937 
cells as well as primary guinea pig alveolar macrophages were used to 
study this adherence phenomenon.
A variety of assay methods were used to evaluate the nature of this 
binding event: transmission electron microscopy and scanning electron 
microscopy were used to visualize the uptake and replicative processes 
while organism enumeration as a measure of adherence was 
accomplished using viable bacterial cell colony counts and indirect 
immunofluorescence studies. It was shown that L. pneumophila adhered
xii
to U-937 cells in the absence of complement and a complete infectious 
cycle for the organism was found. These data confirmed previously 
identified stages of phagocytic host cell interaction including uptake, 
intracellular replication and release of progeny bacteria.
The chemical nature of the L pneumophila bacterial 'adhesin' and 
the host cell ‘ receptor* in binding studies were investigated. The results 
from both competitive binding and surface treatment studies suggested 
the nature of the putative adhesins and receptor moieties associated with 
successful attachment of L pneumophila to these host cells. Glycolipids on 
host cell surfaces and proteins or glycoproteins on Legionella membranes 
function to facilitate binding of bacteria prior to engulfment.
Monoclonal antibodies specific for complement receptors CR1, CR3 
and CR4 were used in blocking studies and these indicated that these 
molecules were not involved in the recognition of legionellae. These results 
indicate the importance of opsonin-independent binding mechanisms for 
L. pneumophila to host cells and shed new light on our understanding of 
cellular infection by L. pneumophila.
xiii
SECTION I
HISTORICAL PERSPECTIVE OF THE GENUS LEGIONELLAAND 
LEGIONNAIRES’ DISEASE.
1.1 Background and Objectives of Study
Legionella pneumophila Is the major organism responsible for the 
potentially life-threatening human pneumonic illness called Legionnaires' 
disease. Outbreaks of this disease either occur in explosive, spectacular 
fashion or take the form of sporadic infections and in either case these 
may be of community based or nosocomial origin (68, 77, 175). Although 
the most notorious outbreak occurred 18 years ago among American 
Legionnaires in Philadelphia, PA (68), to which this disease owes its name, 
many outbreaks have occurred since then. Furthermore, numerous 
outbreaks have been serologically diagnosed retrospectively prior to 1976 
(97,145,173). It was from the Philadelphia epidemic that two very 
important points were forthcoming: first, an entire family of previously 
unidentified microorganisms were identified and second, physicians as well 
as researchers were forcibly reminded that infectious diseases remain a 
major problem afflicting humankind.
Since the late 1970's, several new microbial diseases have been 
identified and these include such newly recognized important infections as
1
Lyme's disease, Campylobacter enteritis and acquired immune deficiency 
syndrome (AIDS) to name but a few. Understanding the physical nature of 
Legionella, identifying aspects of the environment that influence its 
proliferation together with resolving host involvements in the establishment 
of Legionnaires' disease are essential if this pathogen is to be brought 
under control.
This bacterium is a facultative, intracellular, respiratory pathogen that 
induces lobar pneumonia in those infected. The inhalation of aerosolized 
water droplets contaminated with L. pneumophila is the route by which this 
organism gains access into the host's respiratory network and begins the 
colonization of the resident macrophages in the lung (77). This process is a 
necessary prerequisite for the initiation of disease.
Aggressive antimicrobial chemotherapy has been shown to reduce 
the likelihood of patient mortality (68). Alternatives to traditional antibiotic 
treatment are currently being sought for the control of Legionnaires' 
disease. This is particularly important as chemotherapy alone will not 
prevent the initiation of disease and may not on occasion prevent the 
outcome of severe infection. In addition, recurrent infections following 
antibiotic therapy have been reported. Treatment regimes often must be 
broad-ranging in their scope and, reflecting the importance of cell- 
mediated immunity, may require the use of immune system-enhancing 
molecules such as interferon-gamma (IFN-7) and interleukins to augment 
chemotherapy (15,69,189,190). Moreover, these treatments may be
2
most effective if used in conjunction with traditional antibiotic regimes. The 
development of combination therapy programs will undoubtedly assist in 
the effective control of this pathogen.
The purpose of this study was to investigate and evaluate an 
alternative mechanism of Legionella attachment to host cells involving an 
opsonin-independent process. U-937 cells, transformed human 
macrophage-like cells and guinea pig alveolar macrophage (GAM) cells 
were used to  evaluate the adherence of Legionella by this mechanism. By 
identifying the bacterial attachment mechanisms the results of this work 
should augment current knowledge on understanding the fundamental 
processes of Legionella infection of host cells and may assist toward the 
development of a suitable vaccine for Legionnaires' disease.
1.2 The Problem
1.2.1 Background
Legionnaires' disease constitutes a medical problem of significant 
proportions and death due to infection is not uncommon. More data is 
required on the mechanisms of disease induction. Legionellosis is the 
common name for an illness which consists of two disparate disease 
conditions: Legionnaires' disease and Pontiac fever. These conditions are 
caused by what appear to be phenotypically and genotypically identical 
organisms. Legionnaires' disease is a lobar pneumonia, which received its 
name from the Philadelphia epidemic of 1976 (68,114). It is the more 
serious condition caused by L pneumophila and patient recovery
3
inevitably requires medical intervention. Pontiac fever, on the other hand, 
acquired its name from an outbreak in Pontiac, Ml, in 1968 and is a self- 
limiting respiratory illness which presents with flu-like symptoms (77). Factors 
such as the health of the host, the infectious dose, the method of exposure 
and the expression of bacterial virulence determinants by the organism 
undoubtedly offer some explanation for these two variations in disease 
expression.
1.2.2 Philadelphia Outbreak
Immediately following the annual convention of the American 
Legion held in July and August of 1976 at the Bellevue-Stratford hotel in 
Philadelphia. PA, the world witnessed a spectacular epidemic of acute 
febrile respiratory disease (68). The etiology of this disease remained 
unresolved for several months. In the epidemic 216 people developed 
respiratory disease and 34 died (68). Analysis of the 216 identified cases 
indicated that 182 legionnaires' contracted the disease and 29 died. The 
34 remaining cases were people who were at or near the hotel during the 
outbreak and came down with so-called Broad Street pneumonia and of 
these 5 died (68).
During this outbreak, several hypotheses were proposed to  explain 
the etiology of disease and establish the parameters for elucidating the 
causative agent of this outbreak. Initial identification protocols failed to 
establish the etiology of this disease in that commonly available culture 
media and state-of-the-art clinical identification procedures failed to
4
provide definitive information.
In early 1977 Dr. J. McDade from the Centers for Disease Control, 
using isolation procedures to identify rickettsia, demonstrate that the 
etiologic agent of Legionnaires' disease was a hitherto unidentified gram- 
negative, rod shaped bacterium (114). Isolation process involved 
inoculation of homogenized biopsied lung tissue from legionnaires' into the 
yolk sac of embryonated hens' eggs. The organism replicated in the yolk 
sacs which yielded pleiomorphic, carbol fuchsin staining bacilli (114) later 
identified as a new family of bacteria, the Legionellaceoe (20).
Subsequent studies have retrospectively indicated that Legionella 
infections of both epidemic and sporadic forms have occurred previously 
(77, 173)
1.2.3 Pontiac Fever Epidemic
Following the identification of the Legionnaires' disease bacterium, 
retrospective studies were conducted to determine whether previously 
unresolved outbreaks of pneumonic illness were due to infection by L 
pneumophila (95,144,173). Although the Pontiac fever epidemic 
occurred in 1968, the etiologic agent was not identified at the time of the 
outbreak. This epidemic of acute, self-limiting, febrile respiratory illness 
involved nearly all employees of the Oakland County Health Department in 
Pontiac, Ml, during July and August of 1968 and a total of 144 persons 
working at or visiting this facility became ill. In general Pontiac fever 
presents as a mild respiratory illness together with fever and/or chills.
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generalized myalgia, malaise and headache (Table 1.1). The attack rate 
was 95% and the mode of transmission of the pathogen was determined to 
be the building's ventilation system (77). None of the infected persons died 
nor was there evidence of sequelae following this outbreak. Medical 
intervention is not normally required for this form of Legionella-induced 
disease.
It is not understood why Legionella-induced disease presents in 
these two quite different forms, nor are the critical factors governing 
disease expression known. Examination of variations in Legionella-host 
interactions will undoubtedly facilitate our understanding of the disparity in 




Legionellae are fastidious, gram-negative, pleiomorphic, bacilli 
approximately 1-2 jim in length and 0.3-0.9 nm in width (Table 1.2). In the 
lung of either infected humans or guinea pigs, short coccobacillary forms 
predominate (26, 149,156). However, when these organisms are cultured 
on bacteriologic media longer forms abound and these can often be in 
excess of 20 nm in length. Legionellae stain weakly gram-negative with 
safranin but more strongly with carbol fuchsin. The weak safranin staining is 
most likely the result of hydrophobic
6





Historical outbreak named for: Philadelphia, PA Pontiac, Ml
Attack Rate: 1-5% 95%
Incubation Period: 2-10 days 1-2 days
Symptoms: Pneumonia Flu-like illness
Other sites of Infection CNS, G.l. Tract, None
Pericardium and Kidneys
Fatality Rate: 0-40% 0 %
* Legionellosis is the term applied to both illnesses. Legionnaires' disease 
and Pontiac fever are the result of infection by genotypically and 
phenotypically identical organisms.
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Table 1.2: Morphologic Identification of Legionella pneumophila
• Slender gram negative rods (in vivo forms are short 0.5 x l-2(im)
(in vitro forms are elongated 0.4 x 2-3|im)
• Pleiomorphic (long forms can be up to 20-50 i^m in length)
• Tapered ends
• Divide by non-septate, pinching, binary fission
• Possess lipopolysaccharide (major antigenic structure)
• No evidence of acid mucopolysaccharide capsule
• Motile by polar or sub-polar flagella
• Fimbriate
• Blebs on outer membrane surface
• Outer membrane and cytoplasmic membrane each lOnm thick
separated by a thin peptidoglycan layer
• Ribosomes 25nm in diameter
• Internal PpH storage granules
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interactions between the surface of Legionella and the safranin and this 
may be related to the copious amounts of branched chain fatty acids in 
the organism (124) Legionella do not form spores and with the exception 
of L. m icdadei which is weakly acid-fast in lung tissue (127) they are not 
acid-fast.
Legionellae possess two lipid-rich membranes is separated by a 
peptidoglycan layer, typical of gram-negative bacteria. In addition, the 
organisms possess non-parallel sides with tapered ends (26,150, 155). The 
outer membrane and cytoplasmic membrane are approximately 10 nm in 
width and are separated by a thin yet identifiable peptidoglycan layer. This 
structure has been demonstrated with biochemical procedures and has 
been visually identified by electron microscopy (64,155). Division occurs by 
pinching binary fission (150). The lipids produced by legionellae are 
complex and are not of the types typically found on other gram-negative 
organisms. In addition, poly-^-hydroxybutyrate storage granules are
commonly found in Legionella (26,148, 155) The majority of organisms in 
the group are motile by polar or sub-polar flagella (150,153) which are 14- 
20 nm in diameter and up to 8^m in length (135,153,154). The individual 
monomeric flagellin proteins have a molecular mass of 47 kD, as 
determined by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) (136). Unlike organisms grown on laboratory 
media flagella are not usually found on organisms in lung specimens. The 
expression of flagella appears to be temperature-dependent (136).
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Fimbriae (Rodgers) have been identified on the surface of L. 
pneumophila and lipopolysaccharide (LPS) is produced abundantly (131, 
150). The chemical composition of L pneumophila LPS is similar to that of 
many other gram-negative organisms and has been characterized by gas 
chromatography and mass spectroscopy (166). The composition of 
Legionella LPS is typical of that for other gram-negatives with a lipid A 
portion, a 2-keto-3-deoxyoctonate linker region forming 1-13% of the 
carbohydrate present and polysaccharide side chains. Species and 
serotypic differences in the composition of the Legionella LPS make this an 
excellent candidate for serogroup differentiation (25, 131). The LPS is 
smooth and is the primary structure that elicits an antigenic response in 
infected patients (71).
1.2.5 Taxonomy and Nomenclature
Brenner et al. (19) proposed a classification system for the 
Legionnaires' disease bacterium based upon DNA homology and % 
guanosine and cytosine content (mol %G+C). This study demonstrated that 
the organism responsible for the Philadelphia outbreak had not previously 
been described. The proposed family was similarly classified as unique and 
named the Legionellaceae. At the time, this group was determined to 
contain one genus Legionella, and one species pneumophila. 
Subsequently, numerous species have been identified and the family 
currently contains 1 genus, 37 species and 3 subspecies with numerous 
serogroups Gable 1.3). The range of DNA relatedness among the
10
legionellae is great and the serological variability is extensive. An 
alternative to the single genus nomenclature system has been suggested 
(74) with the family Legionellaceae consisting of 3 genera: (1) Legionella (L. 
pneumophila), (2) Taflockia (J. micdadei) and (3) Fluoribacterithe 
autofiuorescent species F. bazemanae. F. dum offiiand F. gormanii). 
However, the simpler and more convenient single genus system is by far 
the most universally accepted format. Isolation of Legionella from clinical 
or environmental samples requires specialized media while identification 
involves the use of molecular and serological procedures. Furthermore, it is 
known that legionellae grow exclusively on L-cysteine containing buffered 
charcoal yeast extract (BCVE-a) media (41,184) and this feature greatly 
assists isolation procedures.
1.3.3 Biochemical Properties
Due to the cultural fastidiousness of this organisms and its strict 
requirement for both L-cysteine and ferric salts, commonly available 
laboratory media fail to  grow legionellae. Indeed, initial studies dealing with 
the physiology of L. pneumophila were based on the development of 
media capable of cultivating the organism. The bacteria in the group are 
catalase positive while oxidase, hippurate, gelatinase, and p-lactamase
expression are either variable or species dependent. In addition, some 
species show a brilliant blue/white or red autofluorescence under 
longwave UV and this may prove useful for identification (Table 1.3)
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Using radiolabeled amino acids and carbon sources, the 
biochemical pathways of nutrient utilization for L pneumophila have been 
elucidated. Pine et al. (139) demonstrated that carbohydrates were not 
used as energy sources for legionellae. Indeed, the production of 
metabolic energy is primarily derived from the breakdown of amino acids 
such as glutamate, serine and threonine. i*C labled glutamate revealed 
biosynthetic utilization with approximately 29% of this substrate traced to 
lipid, 21% to protein, 16% to nucleic acid, 9% to miscellaneous 
polysaccharides and 24% to small molecular weight compounds (171). 
Legionellae are strict aerobes and the utilization of carbohydrates occurs 
via oxidative processes as opposed to fermentation (139, 180,181). 
Glucose is metabolized and the resultant energy is used in a maintenance 
rather then in a biosynthetic fashion. When glucose metabolism occurs, it is 
preferentially broken down by Entner-Doudoroff and pentose-phosphate 
mechanisms rather then by glycolytic processes (172).
The cellular fatty acid content, in particular branched chain fatty 
acids, of L pneumophila is not consistent with that of other gram-negative 
bacteria (124). Moreover, the fatty acid profile differs somewhat between 
species of the genus. The majority of lipids produced by Legionella are (iso- 
16:0) carbon compounds and in particular methyl-14- 
methylpentadecanoic acid. Such 16-carbon compounds make up 
greater then 30% of the total cellular fatty acid content of the organism. 
Other lipids are produced by L. pneumophila and include the polymeric 
poty-{J-hydroxybutyric acid (PBH) which was demonstrated by sudan black
12
Table 1.3: Biochemical Identification for the Genus Legionella
AF
L. pneumophila 14 H/E + V + + + +
L micdadei 1 H/E + + - - - +
L bozemanii 2 H/E + V - + V BW +
L. dumoffii 1 H/E + - - + + BW +
L. gormanii 1 H/E + - - + + BW +
L. longbeachae H + + - + V +
L jordanis 1 H/E + + - + + +
L oakridgensis 1 H/E + - - + +w -
L. wadsworthii 1 H + - - + + +
L feelii H/E + - V - - +
L sainthelensi 1 E + + - + + +
L anisa 1 E + + - + + BW(V)+
L maceachemii 1 H/E + - - + - +
L. jamestowniensis 1 E + - - + + +
L. rubrilucens 1 E + + - + + R +
L eryihra E + + - + + R +
L. hackeliae H +W + - + + +
L. speritensis 1 E + + + + + +
L. parisiensis 1 E + + - + + BW +
L. cherrii 1 E + - - + + BW +
L stigerwaltii 1 E + + - + + BW +
L sainticrucis 1 E + - + + + +
L isriaelensis 1 E + - - + + +
L birminhamensis 1 H + V - + + YG +
L cincinnatiensis 1 H + + - + - +
L. moravica 1 E + +w - + + +
L. brunesis 1 E + - - + + +
L quinlivanii E + - - + - +
L. tucsonensis 1 H + - - + + BW +
L. fairfieldensis 1 E +W +W - - - +
L. adelaidensis 1 E + - - + - +
L shakespearei 1 E + +w - + - +
L. geestiana 1 E + - + + - +
L bndiniensis 1 E +w - +/- + + -
L. naurtarum 1 E + + - - + -
L. quateirensis 1 E + - - + + +
L. worsleiensis 1 E + ” • + + +
+= posative reaction; - = negative reaction; V= varriable results; w= weak 
Cat= catalase; Ox= oxidase; p-Lac= p-lactamase; Hip= hipurate; M= Motility 
GL= gelatin luquificatton; AF= autofluorescence 
H= human origin; E= environmental origin 
YG= yellow-green; R= red; and BW= blue-white fluorescence.
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staining and transmission electron microscopy (150, 181).
Numerous organic substrates and inorganic compounds are 
necessary for the laboratory cultivation of legionellae. Initial laboratory 
cultivation of legionellae on agar media demonstrated a requirement for 
hemoglobin and this specific requirement for high levels of iron is met by 
the addition of ferric pyrophosphate to BCYE -a media (143). Other ions
which are essential to Legionella cultivation include trace amounts of Ca, 
Co, Cu, Mg, Mn, Na, Ni, V and Zn (143). In addition to these metal ions, 
charcoal and a-ketoglutarate are important facilitators for organism 
growth on laboratory media. The role played by these materials appears 
to  be the detoxification of BCYE-a. it is suggested although not proven that
they serve the purpose of either inactivating toxic activity of oleic acid or 
of scavenging toxic oxygen radicals generated from the process of 
autoclaving the yeast extract in the medium.
1.3.4 Physico-chemical Properties
In the environment legionellae experience a wide variety of 
conditions which often prove bactericidal in nature; these adverse 
conditions include pH variations, exposure to ultraviolet radiation (UV) and 
temperature fluctuations. L pneumophila grow optimally on laboratory 
media between pH 6.85- 6.95 at 37°C and in the presence of 2.5% CO2 .
The bacterium is more sensitive to UV irradiation than many other gram- 
negative bacteria including Escherichia coli, Salmonella typhi, Serratia
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marcescens and Pseudomonas aeruginosa (5). Organisms from 
environmental or clinical isolates grow a t temperatures ranging from 25°C- 
43°C; however, multiplication and growth do not readily occur at 50°C or 
above (65, 181). Legionella selection from clinical and environmental 
samples usually involves either acid or heat treatment. Edelstein et al. (47) 
showed a marked increase in Legionella recovery from clinical samples 
using heat treatment a t 60°C for 1-2 min while Bopp et al. (18) and 
Buesching et al. (20) demonstrated the usefulness of acid treatment of pH
2.2 for 4 min to enhanced organism recovery from both environmental and 
clinical specimens. Legionella are sensitive to alkaline treatment (pH 8.0); 
however, their sensitivity to chlorine is inconclusive as organisms in 
association with protozoa appear to be more resistant to chlorine then 
free-living organisms (41,97,164).
1.3.5 L. pneumophila Growth on Bacterioloaic Media
L. pneumophila are nutritionally fastidious organisms which require 
strict conditions for growth. Feeley and Gorman (57) first demonstrated 
that Legionella could be cultivated, but only poorly, on Muller-Hinton agar 
supplemented with 1% hemoglobin and 1% IsoVitaleX in the presence of 
2.5% CO2 (57). In subsequent media formulations Feeley et al. (57) 
optimized the growth of Legionella in the laboratory by demonstrating that 
this organism has an absolute requirement for L-cysteine and ferric 
pyrophosphate. This novel medium formulation was named Feeley- 
Gorman (F-G) agar. Further physiologic studies by Feeley et al. (56)
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demonstrated that media with yeast extract and activated charcoal 
facilitated recovery and enhanced growth of legionellae. This new media 
was called charcoal yeast extract (CYE) agar (55). A further modification 
of CYE agar, introduced by Pasculle (136), involved buffering this media 
with N-2-acetamido-2-aminoethanesulfonic acid (ACES) buffer to give 
BCYE agar. The latest refinement introduced by Edelstein (42) added a-
ketoglutarate to  BCYE to give BCYE-a and this is the current standard for
cultivation of legionellae.
Chemically defined culture media have been developed (101,139) 
but these have been used primarily to determine the nutritional 
requirements of this genus. The use of defined media in conjunction with 
alternative growth systems may help to  identify and define growth rate- 
dependent virulence characteristics and may aid in ascertaining the role 
these factors play in the infectious process.
1.3.6 Genetics and Molecular Bioloav of the Organism
Although the understanding of Legionella interactions with host cells 
at the cellular and molecular levels is paltry at best, even less is known 
about the genetic regulation and expression of those virulence factors 
responsible for the establishment of disease. The majority of early genetic 
investigations were directed toward the identification of Legionella in 
environmental or clinical samples. Genomic sizing studies demonstrated 
that the chromosome of the Legionella is approximately 2.5 x 109 daltons
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(19). Legionellae possess a guanosine + cytosine DNA content which 
ranges from 38-52 mol% and averages 39 mol % (48). Recently, 16S 
ribosomal RNA studies and DNA hybridization have indicated that the 
Legionellaceae are not closely related to other eubacteria (70,160). In 
addition, several DNA probes are commercially available for the detection 
of legionellae from either clinical or environmental specimens (42,174).
Extra chromosomal DNA in the form of plasmids is frequently isolated 
from legionellae (107,116). The 80-megadalton plasmid is common among 
many strains of this organism; however, the role of these plasmids is 
unknown (19,100,107,120,135). Often the plasmids of other bacteria 
have been shown to harbor genes responsible for virulence traits such as 
antimicrobial resistance while others directly induce virulence factors such 
as toxin expression. This does not appear to be the case with Legionella in 
which the presence or absence of plasmids do not modify antimicrobial 
resistance patterns nor change expression of virulence traits. It would 
appear from this that plasmids apparently play no part in the expression or 
establishment of disease.
Cloning of Legionella DNA fragments into other organisms has been 
done successfully using E. coli as the recipient. Results however, are less 
then promising when plasmids of other organisms are inserted into 
Legionella (28,37). In an early study in which Legionella fragments were 
cloned into E. coli an interesting virulence prolein was revealed and this 
was involved with uptake of Legionella by macrophages (29,51,52). Other 
genes of L pneumophila have been successfully cloned into E. coli
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including the gene responsible for the expression of the major outer 
membrane protein (80). a zinc metalloprotease (140) and a 19-kDa outer 
membrane peptidoglycan-associated protein (106). In addition, several 
highly conserved genes have been cloned into E. coli including the recA 
gene (for homologous repair of DNA) and the groELS gene (for production 
of heat-shock proteins) (36,81,192). However. E. coli although effective as 
a cloning system may not be best suited for expression of Legionella inserts 




The precise processes by which legionellae infect host cells and thus 
induce human disease are not well understood. To characterize the 
mechanism of Legionella infection and to define the role these processes 
play in Legionella pathogenesis investigations on the infectivity of the 
bacterium have been performed using animal systems and a number of 
primary, secondary and transformed cell lines (Table 1.4). Various animal 
models have been evaluated for their ability to mimic the pathogenesis 
and pathology of human disease. Hamsters, several mouse and rat strains 
as well as guinea pigs have been proposed as models for human 
Legionnaires' disease (10,183,191). The guinea pig has proven the most 
effective animal for the evaluation of systemic disease. Recently A/J mice 
have been investigated for their effectiveness at assessing several aspects
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of mymicing the intracellular infection seen in human disease (191). Given 
that the mouse is well established for investigating other host-pathogen 
interactions and has a well characterized immune system the development 
of an effective mouse model for Legionnaires' disease would prove 
extremely useful for evaluating L. pneumophila interactions with the 
immune system in disease. Not only is the mouse immune system better 
understood then that of other animals but an extensive array of mouse 
immune modulators are available and functionally characterized for use in 
investigations. Such modulators include interferons, various interleukins, 
tumor necrosis and colony stimulating factors. Such a model could help 
elucidate the interaction of these modulating molecules with the pathogen 
and might eventually influence treatment regimes.
To better understand the events of Legionella infection a t the cellular 
level researchers have used host cells from a variety of origins. These in 
vitro studies have used either transformed or non-transformed cells of 
epithelial, fibroblast, polymorphonuclear and mononuclear lineage (76,87,
111,134,152). Most of these cells have been shown to support L 
pneumophila infection; however, while human macrophages and 
monocytes support the growth of the organism polymorphonuclear 
leukocytes (PMNL) do not. Rather, these cells support an abortive type 
infection and this cell is relatively ineffective for studying cellular infectivity 
of legionellae (16,88). These studies have proven important in defining 
which cells support Legionella replication and in outlining the ultrastructural 
events of intracellular infection. Furthermore, the establishment of an
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appropriate cell model for the study of the cellular events in Legionnaires' 
disease is necessary as human alveolar macrophages are not readily 
available.
Since the alveolar macrophage is the target cell in the lungs, 
macrophages or macrophage-like cells appear to be most useful for 
studying uptake, intracellular multiplication and release of bacterial 
progeny. In addition to studies with mononuclear phagocytes, 
investigations with epithelial and fibroblast cells which do not possess the 
same receptors as macrophages have shown that L. pneumophila binds to 
the cells and despite the lack of receptors these cells support a complete 
infectious cycle of the organism. These studies indicate that alternative 
mechanisms of cellular infection exist and that certainly those processes 
that occur independent of opsonins and/or complement receptors may 
constitute a primary mechanism by which cells are parasitized by L 
pneumophila (75, 152).
A variety of studies have extensively investigated Legionella infection 
of monocytes and macrophage-like cells, as these cells are the most likely 
candidates for successful establishment of human infection (75,82,111,
138,152). Those cells most frequently used include human peripheral blood 
monocytes and the cell lines U-937 and HL-60 (75,87, 111, 138,152). The U- 
937 cell has shown particular promise as a model for studying cellular 
infection as this cell has been used extensively in studies of both 
attachment and intracellular replication of Legionella (75,76,91,138,152). 
These cells possess Fc and complement receptors at levels consistent with
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human alveolar macrophages (157). This, in conjunction with a similar 
intracellular replication kinetics profile for L pneumophila, makes these cells 
an attractive model for studying L pneumophilo-hosi cell interactions. 
Furthermore, the U-937 cell has been useful for studying the interactions of 
other intracellular pathogens such as Salmonella with macrophage-like 
host cells (2).
Adherence of L. pneumophila to  a host cell is a necessary prelude to 
intracellular infection (11). Recent studies suggested that the mechanism 
used by bacteria to adhere to cells was central to the establishment and 
outcome of disease (178, 182, 187, 188). Two mechanisms of L 
pneumophila attachment to host cells have been reported (75,88). One is 
mediated by opsonins while the other operates independent of opsonins.
In the opsonin-dependent system Legionella uptake is mediated by the 
complement component C3bi and the host cell complement receptor 
type 3 (CR3). C3bi is deposited on the major outer membrane protein 
(MOMP) on the surface of Legionella and the MOMP/C3bi complex binds 
to CR3 on human monocytes (12). The opsonin-independent uptake 
mechanism occurs in an environment devoid of complement or specific 
antibody (75,76,152) and has been shown to produce a normal bacterial 
replicative cycle in U-937 cells (75,152), as well as in MRC-5, HEp-2 and 
Vero cells (134).
Following complement-dependent adherence, Legionella organisms 
are internalized by monocytes via coiling phagocytosis (83) and internalized 
organisms are contained within banded enclosures (134). Shortly
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thereafter, phagosomes containing organisms become ribosome-lined 
and are found in close association with mitochondria. The significance of 
these observations is, as yet, unknown; however, these processes may be 
important for the survival of this organism within host cells. Once the 
bacterium is internalized survival depends on the inhibition of phagosome- 
lysosome fusion within infected mononuclear cells (82). The mechanism by 
which Legionella inhibit phagosome-lysosome fusion is not understood. 
Research in this area would add to  our understanding of the molecular 
events critical for Legionella survival in the inhospitable environment of the 
macrophage. Phagosome-lysosome fusion is one step in a series of normal 
degradative process by which foreign material is destroyed within 
phagocytes. The inhibition of these functions results in fulminant parasitism 
of infected macrophages and is closely followed by unabated intracellular 
replication of the organism.
Alternative mechanisms of intracellular survival are used by other 
facultative intracellular bacterial pathogens (60,165). Some organisms 
such as Listeria monocytogenes breakdown the structural integrity of the 
phagosome and escape into the cytoplasm prior to phagosome-lysosome 
fusion (125). Others, like Mycobacterium leprae, persist within phagosomes 
that have fused with lysosomes and despite this bacteria actively multiply 
within this hostile environment (125).
Following the course of unchecked intracellular multiplication, 
legionellae escape from infected macrophages. The release of 
legionellae from the confinements of the host cell phagosome is then
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followed closely by organism escape to the extracellular milieu. Release 
facilitates continuation of disease as progeny organisms initiate infection of 
other cells in the surrounding tissues. Legionellae are released from 
infected host cells by lysis (Table 1.4). The process by which Legionella 
organisms escape the phagosome and the host cell cytoplasmic 
membrane is as yet undefined; however, the major secretory protein of 
Legionella, a zinc metalloprotease with powerful cytotoxic potential, may 
play an important role in this process.
The terminal line of constitutive defense in the lung is the alveolar 
macrophage and this is important for the destruction of foreign material 
arriving in the lower respiratory tract. However, it is this cell which 
Legionella preferentially infects; the very cell designed to eradicate it. The 
cell-mediated branch of the immune response is critical to recovery from 
Legionnaires' disease. However, it is unclear whether humoral defenses 
also play a part in recovery or immunity to infection (89,91). Opsonization 
of Legionella with specific antibody enhances the adherence of this 
organism to mouse macrophages, as well as to U-937 cells and it has been 
suggested that without specific antibody complement may not enhance 
the uptake of L pneumophila (91).
Iron is a requirement for the growth of most bacteria including 
pathogens whose virulence is frequently enhanced by iron (66). L. 
pneumophila has a strict requirement for high concentrations of iron to fuel 
metabolic activities. During infection of monocytes, L pneumophila 
sequesters iron from the intermediary labile iron pools of the host cell.
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However, the mechanism legionellae use to obtain the iron necessary for 
continuation of disease is not known. This iron pool is formed from iron- 
transferrin and iron-lactoferrin via transferrin and lactoferrin receptors 
respectively. Furthermore, iron is also available in the protein-bound form, 
ferritin. Intracellular replication of legionellae can be inhibited by treating 
monocytes with substances which decrease iron availability (22,23,24). 
These known inhibitory agents include iron chelators such as apolactoferrin 
and deferoxamine, agents which interrupt the evolution of iron from iron- 
transferrin like ammonium chloride and chloroquine as well as molecules 
that normally down-regulate transferrin receptors such as gamma 
interferon (IFN-y) (22,23).
L. pneumophila is incapable of intracellular replication within PMNLs 
whether or not these cells are in the presence of IFN-y, specific antibody or
complement. Moreover, PMNLs are not appreciably involved in the killing 
of legionellae, yet they may play a role in determining the eventual 
outcome of infection. Indeed, depletion of PMNL from the lungs of guinea 
pigs was shown to  be detrimental to recovery (62). A mechanism that may 
explain the role of PMNLs during infection suggests a cooperative effect of 
PMNLs with monocytes or macrophages. At the site of infection PMNLs 
release large quantities of apolactoferrin that could be taken-up by 
infected cells. The concomitant reduction of iron availability following the 
uptake of this chelator would effect the reduction of intracellular 
replication of L. pneumophila. As cell parasitism occurs with or without
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PMNLs, the inhibitory mechanism suggested would be only partially 
effective for control. Augmentation or enhancement of this 
bacteriostatic-type system may help to control infection and requires 
further investigations.
L pneumophila has been shown to produce various toxins including 
legiolysin (a hemolysin), endotoxin (LPS) and a tissue destructive protease 
(13,38). However, little is known about the role these molecules play in the 
development of disease. Cytopathology of destroyed lung tissues 
previously infected by L. pneumophila is suggestive o f cytotoxic activities 
(10, 14,183) (Table 1.5).
The protease of L. pneumophila, the major secretory protein, has 
been described as one of the more important molecules produced by the 
organism during infection. During the initial identification studies following 
the Philadelphia epidemic, a toxic etiology was suggested as an 
explanation of this outbreak (68). The organism produces a protease and 
this molecule was determined to  possess both caseinase and gelatinase 
activities. Further investigations have identified the Legionella protease as 
a zinc metalloprotease with a molecular mass of 38,000 to 40,000 (38,140). 
Hemolytic, cytotoxic and tissue destructive properties have been 
demonstrated for this molecule. Whether the protease is necessary as an 
important mediator of cell parasitism leading to establishment of infection 
or as a molecule essential for organism escape from infected cells is not 
known. Studies have indicated that the protease is produced primarily 
while the bacterium is within host cells and little is secreted when the
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Table 1.5: Structural Virulence Factors of Legionella pneumophilae
Structure Characteristics
Fimbriae Putative adhesin
Flagella Common Antigen for 
Serogroups 1-3 
Putative Adhesin
Li popoly saccharide Activates Complement 
Cascade 




Major Outer Membrane Protein Genus Specific Epitope 
Species Specific Epitope 
C3 Acceptor Molecule 
Putative Adhesin
Legiolysin Hemolytic properties
Major Cytoplasmic Membrane Protein Heat Shock Protein (Hsp60/65) 
Potent Stimulator of Humoral 
Response 
Genus Specific Epitope
Macrophage infectivity Potentiator Potentiates infection of 
mononuclear phagocytes 
Inhibits activity of host cell 
Protein Kinase C
Major Secretory Protein Zinc Metalloprotease 
Cytotoxic for CHO cells 
Produced intracellularty within 
monocytes
a Observations primarily associated with human disease
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bacterium is in the extracellular menstruum. However, strictly controlled 
physiologic in vitro studies have not been done to investigate these 
processes.
In addition to cytotoxic activity, hemolytic activity has been 
described for L. pneumophila (14.69,98,188). Legiolysin, the hemolysin of 
L. pneumophila is a 39-kDa protein which has been studied and has been 
cloned into E. coli. This hemolysin also confers the additional phenotypic 
characteristics of brown pigment formation on tyrosine containing media, 
as well as mediating colonial auto-fluorescence in longwave UV light (186). 
Despite cloning of the gene and partial characterization of this molecule, 
little is known about the role this structure plays in the pathogenesis of 
Legionella infections.
As is the case for the majority of gram-negative bacterial pathogens, 
L. pneumophila produces lipopolysaccharide (LPS). Initial investigations 
have provided contradictory evidence for the role of L. pneumophila LPS 
in virulence. LPS can activate the classical complement cascade (121); 
however, the precise nature of this process remains obscure. Legionella 
LPS is also the major immunogenic structure on the surface of this 
bacterium (71). Moreover, LPS can induce the production of immune 
modulators in mouse spleen cultures including interleukin-1 and interleukin- 
2, IFN~y and tumor necrosis factor (16,17).
Other Legionella proteins have been shown to  play at least some 
role in the pathogenesis of Legionnaires' disease. The macrophage
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infectivity protein (MIP) was shown to  be important for uptake of L. 
pneumopNIa by macrophages (30.31). This molecule is a 24-kDa 
molecular mass protein the gene for which has been cloned into E. coli and 
sequenced (29.51,52). The MIP protein was shown to  be conserved 
across the genus; however, there are notable variations in the migration 
pattern of the MIP protein between species (31).
1.4.2 Environmental Aspects
The ability of L. pneumophila to replicate within phagocytic 
freshwater amoebae was initially reported by Rowbotham (147). In 
subsequent years, several reports have confirmed that legionellae can 
multiply within a variety of protozoa including Acanthamoeba 
castellanii.Naeglaria fowleri, Hartmanneiia vermiformis and the ciliated 
protozoa Tetrahymena pyriformis (59 122,130). Several studies have 
identified environmental sources in which L pneumophila organisms 
survived and have been shown to be responsible for several outbreaks of 
legionellosis (8,58). In some cases, the protozoa isolated from these 
reservoirs have been shown to support the growth of Legionella in vitro 
(58). To date, there is no evidence to support the multiplication of 
Legionella organisms in an environment devoid of protozoa or host cells.
The mechanism by which Legionella parasitize protozoa in the 
environment has yet to be defined. Furthermore, the characterization of a 
receptor on the surface of the amoebae that is responsible for the 
attachment of L. pneumophila has not been identified. Several research
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groups have suggested that human infection by legionellae is a 
coincidental event in that Legionella may recognize a highly conserved 
structure on the surface of the alveolar macrophage which structurally 
mimics that on amoebae. A valid case can be made for coincidental 
human infection since humans form a dead-end host with no known 
mechanism for human to human transmission. This putative conserved 
surface structure located on amoebae and lung alveolar macrophages 
may allow for attachment and facilitate uptake, or allow for intracellular 
replication of L. pneumophila within these cells.
The mechanism of adherence for L. pneumophila to protozoa has 
yet to be identified; however, this organism has been shown to attach to 
human monocytes via two different molecular mechanisms, one of which 
requires complement, while the other process occurs in an opsonin- 
independent fashion (76,88). In the natural aquatic environment, 
complement-mediated uptake is an unlikely process, but rather this 
mechanism would involve an 'adhesin '-'receptor' complex arrangement 
between L pneumophila and amoebae. Thus it is believed that Legionella 
may parasitize the alveolar macrophage at the earliest stage of organism 




Legionellae are not primary pathogens for humans, but rather are
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opportunists which cause severe disease. For infection to occur, L. 
pneumophila must be presented to the host in aerosol form and the 
inhalation of small water droplets is necessary for colonization to occur 
(183). Confirmed cases of legionellosis must be reported to  state health 
authorities and to the C.D.C. to facilitate national surveillance of this 
infectious disease. There are approximately 1300 cases of legionellosis 
annually and the incidence has shown a general rising trend since its first 
appearance (Fig. 1.1 and Fig 1.2). It has been suggested that the 1300 
annual cases is a conservative or much underestimated figure and that 
there may be up to 100,000 cases of legionellosis per year (85). L 
pneumophila serogroup 1 is responsible for 85% of all reported cases of 
community-acquired legionellosis while other serogroups of L. pneumophila 
and L. macdadeii make-up the remainder.
Legionella spp. have been isolated from a wide variety of fresh 
water environments. The organisms is ubiquitous in lakes, ponds, streams, 
thermal lagoons, muds, sediments and potable water supplies (67,126). In 
addition, legionellae have been isolated from shower heads, whirlpools, 
spas, respiratory therapy equipment (6,126) and supermarket vegetable 
water misting systems (108). Legionella have also been found to 
contaminate potting soil mixes (168).
In the environment, phagocytic amoebae are believed to play a 
major role in the survival and persistence of Legionella and, prior to 
amplification of this organism followed by colonization of water supplies 
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Figure 1.1: Total number of cases of legionellosis as reported by the Center 
for Disease Control and Prevention (CDC) Atlanta GA.. Adapted from 
C.D.C. Morbidity and Mortality Weekly Reports, Summary of Notifiable 
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Figure 1.2: Total number of cases of legionellosis per 100,000 people as 
reported by the Center for Disease Control and Prevention (CDC) Atlanta 
GA.. Adapted from C.D.C. Morbidity and Mortality Weekly Reports, 
Summary of Notifiable Diseases, United States 1992.
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Figure 1.3: Total number of cases of legionellosis per 100.000 as reported 
by each state as documented by the Center for Disease Control and 
Prevention (CDC) Atlanta GA.. Adapted from C.D.C. Morbidity and 
Mortality Weekly Reports, Summary of Notifiable Diseases, United States 
1992.
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(8,147). The establishment of a cell model for investigating Legionella 
interactions with protozoa is necessary for understanding the normal 
events of Legionella persistence in the environment.
Inhalation of contaminated aerosolized water droplets is the normal 
route of infection; however, use of contaminated water on bandage 
dressings as a follow-up to invasive surgical procedures has lead to the 
development of systemic Legionnaires' disease (105). The normal 
operation of evaporative cooling systems generates and disseminates 
aerosols. Those small water droplets, approximately 5-15 nm in diameter, 
remain airborne and, when inhaled, are not entraped by the constitutive 
defenses of the upper respiratory tract. On the other hand, they are large 
enough to contain Legionella organisms. On descending into the lower 
respiratory tract to water droplets impinge on the walls of the alveolar sacs 
where organisms are taken-up by alveolar macrophages. These cells are 
not readily able to destroy Legionella organisms without prior sensitization. 
The result of this phenomenon is development of severe lobar pneumonia 
especially in the immunocompromised.
Community-wide outbreaks are uncommon; however when they do 
occur these outbreaks are usually spectacular in nature and are most 
frequently attributed to evaporative condensers or cooling towers which 
harbor the organism (68,77,173). More frequently, nosocomial and 
sporadic cases contribute to the bulk of yearly reported incidence of 
legionellosis.
Men are more frequently infected by L. pneumophila than women
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and infection in children is rare. Imunosuppressed patients are most 
susceptible to infection while other at risk groups include patients with high 
alcohol intake, heavy smokers, people recovering from invasive surgical 
procedures and others suffering from underlying conditions or infections 
such as lymphomas, leukemia and AIDS (7,105).
1.5.2 Clinical Presentation
The incubation period for Legionnaires' disease is 2-10 days (68) and 
the prodromal symptoms include fever, chills, malaise, anorexia and 
weakness, and occasionally headache and myalgia (68). As infection 
proceeds, the acute onset of headache and fever occurs. Pulmonary 
disease predominates and within 3-5 days from the onset of symptoms, 
patients will likely require hospitalization and intensive care. The cough 
associated with early-stage Legionella infection is usually nonproductive; 
however, as the disease proceeds, the cough may become productive 
with a rust colored (blood tinged) or non-purulent sputum. Later in 
infection, lung function is compromised, purulent sputum is produced and 
patients undergo major systematic changes with abnormal liver function 
tests, blood gas and electrolyte imbalances and signs of confusion, 
respiratory collapse and cardiac failure. Patients require intubation and 
aggressive intervention-type therapy along with appropriate antibiotics. 
Despite these procedures, patients often fail to respond.
Radiological examination of the lungs of infected individuals shows a 
picture consistent with lobar pneumonia (184). Patchy unilateral infiltrates
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are noted a t the initial stages of disease, while bilateral infiltrates are noted 
in up to two-thirds of patients (54,98). Extension of these infiltrates 
continues with subsequent consolidation evident in one or more lobes of 
the lung. The infiltrates can persist for up to several months after patient 
recovery. Nodular lesions may be present and can resemble the lesions of 
some fungal infections (33). Plural effusions are common but abscesses 
are rarely seen by radiologic examination. This is in contrast to the 
pathologic study of tissue specimens in that the lungs of fatal cases of 
Legionnaires' disease frequently show abscess formation (184).
Pathologic examination of lung specimens indicates that 
Legionnaires' disease is a multifocal pneumonia with coalescence in the 
late stages of disease (184). The distal airways including the alveoli and 
terminal bronchioles are primarily affected while the proximal bronchioles 
and bronchi are not usually involved. Lesions induced by this organism are 
distinct and are similar for all pathogenic species of Legionella (184); 
however, in some cases, these lesions are difficult to distinguish from 
classical pneumococcal pneumonia. Lung exudates are fibrinous and 
primarily contain neutrophils and macrophages; however, given this 
exudate development during infection the lack of sputum production is not 
understood.
Extrapulmonary involvement can occur during severe cases of 
disease, but these events are more common for L. pneumophila-induced 
disease than for disease caused by other members of the genus (3). 
Bacteremia has been documented (47) and extrapulmonary infections
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include cerebral microglial granuloma, cutaneous and hepatic abscess 
formation, endocarditis, pericarditis and pyelonephritis (3,31,47,63,112,
113,146). Intra-alveolar fibrosis is common and permanent sequelae 
including decreased pulmonary function are common (27,102).
it is unclear whether resistance occurs in people who have 
previously been infected with the Legionnaires' disease. Studies with 
guinea pigs have indicated that protective immunity is conferred on 
animals which were challenged by intraperitoneal injection of killed 
Legionella antigens, but similar studies using aerosol challenge to guinea 
pigs did not prevent infection (51).
1.5.3 Diagnosis
By comparison with those more frequent causes of pneumonia such 
as (Streptococcus pneumoniae and Hemophilus influenzae) the incidence 
of Legionnaires' disease is relatively low. However, the reported incidence 
of Legionella-induced pneumonia from multi-center studies of pneumonic 
illness (100 or more cases of pneumonia) indicates a relatively high 
percentage of these cases are of Legionella origin (55,184). Difficulties 
associated with the clinical diagnosis of L. pneumophila infections due to 
the similarity of symptoms and radiographic analysis of disease induced by 
Legionella and other microorganisms and viruses are common. To add to 
the difficulties in identifying Legionella-induced pneumonia, these 
organisms are intracellular pathogens and as such do not stain well using 
conventional grams stain procedures. Therefore, other identification
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criteria including antigen or nucleic acid detection, and serological 
techniques are implemented to augment conventional laboratory culture 
when Legionella-induced pneumonia is suspected.
However, the gold standard for the diagnosis of L. pneumophila is 
cultivation (42). The legionellae are nutritionally fastidious and will not grow 
on conventional laboratory media. BCYE-a is the medium of choice for
growth and identification of this pathogen. The sensitivity of cultivation 
ranges from 50-80%; It is, however, 100% specific (42, 185). L. pneumophila 
colonies possess a characteristic opalescent, cut glass appearance with 
smooth entire edges and these colonies, which present in a variety of sizes, 
appear 3-5 days after inoculation of clinical material onto this media. 
Several versions of BCYE-a have been developed to make this medium
selective for legionellae from both clinical and environmental samples.
Two semi-selective media have been created: the first, BMPA media, 
includes the antimicrobials cefamandole, polymyxin B and anisomycin (44) 
while the Wadowski-Yee formulation includes glycine a potent inhibitor of 
gram negative bacteria together with cefamandole, polymyxin B and 
anisomycin (179). These remove contaminants which would otherwise, 
quickly outgrow the legionellae. It has been suggested that all three media 
formulations should be used for the isolation of legionellae as some species, 
especially L. micdadei. are inhibited by the antibiotics present in these two 
selective media formulations. In addition to bacteriologic cultivation, 
laboratory identification frequently includes the use o f direct
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immunofluorescence, nucleic acid probes, radioimmunoassay (RIA) and 
polymerase chain reaction (PCR) technology (44,79,108,168,174).
Other additions to the basic BCYE-a media formulation include
bromocresol purple and bromothymol blue, the presence of which 
enhance the recognition of some Legionella species, but affords no 
advantage or a disadvantage for organism growth. Although albumin 
enhances the recovery of L bazemanii and L micdadei from tissue 
samples It does not affect the recovery of L. pneumophila from specimens 
(123).
1,5.4 Antimicrobial Chemotherapy
Without an effective vaccine for the prevention of legionellosis a 
combination of aggressive antibiotic and clinical intervention is required for 
the successful treatment of infected patients. Following the Philadelphia 
outbreak, epidemiologic studies indicated that those who received 
erythromycin therapy fared better than those individuals who had received 
other antibiotics (68). Few antimicrobial agents have proven effective for 
the treatment of Legionella pneumonia. On the other hand, in vitro studies 
have demonstrated that legionellae are sensitive to  an extensive array of 
antibiotics (151,177, 178). The macrolides have proven most efficacious 
for the treatment of Legionnaires' disease. Although erythromycin is the 
drug of choice for the therapy of legionellosis, this antibiotic is not well 
tolerated by some people and causes peripheral phlebitis and intestinal
40
upset. Other mocrolides and alternative antibiotics may be used while 
others are continuously sought and tested for clinical use (45.46,78,151).
A major criterion for the efficacy of any antimicrobial agent in the 
treatment of Legionnaires' disease is membrane transportability. As 
legionellae are facultative intracellular pathogens antibiotics must enter 
the host cell for effective activity. Erythromycin penetrates cell 
membranes well and for this reason it Is the drug of choice of 
Legionnaires' disease. In severe, potentially life-threatening cases, rifampin 
and other antibiotics are often used in combination with erythromycin (9).
Several studies have suggested that other antibiotics may be 
effective for the control of this disease (45,177). One such group of 
promising antimicrobials are the fluoro-substituted quinalones. Of this 
group, ciprofloxacin was shown to be particularly effective for treatment 
of Legionnaires' disease both in vitro, as well as, in clinical trials (129,177). 
Tzianabos and Rodgers (177) extensively studied the in vitro effects and 
demonstrated that ciprofloxicin, like erythromycin, was effective against 
intracellular organisms and hence Legionnaires' disease. In subsequent 
studies, clinical trials have shown ciprofloxicin to be effective for the 
treatment of human legionellosis.
1.6 Comment
During the past 18 years, vast amounts of information have amassed 
concerning many of the major physiologic and pathogenic facets of L. 
pneumophila. In addition, procedures necessary for the diagnosis and
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identification of the organism leading to the establishment of legionellosis 
have been forthcoming. However, Legionella-induced pneumonia is still a 
major cause of respiratory illness. This organism will continue to be of 
clinical importance until an effective vaccine has been developed. It is 
unlikely, however, that a vaccine will be available in the very near future 
since many of the immunological processes involved in the development 
or recovery from Legionella-Induced pneumonia are still unclear. To help 
control legionellosis work must continue in the area of host-cell interaction, 
both in the environment in terms of Legionella-protozoa interactions, as well 
as, in the clinically significant areas of organism-macrophage interaction 
and intracellular survival. Indeed, given the intracellular nature of 
Legionella, a vaccine which prevents the intracellularization of the 
organism should interfere with the prosecution of the disease within the 
lungs. The development of such a vaccine should prove an effective and 
viable alternative to antimicrobial chemotherapy for the prevention and 




INTRACELLULAR REPUCATION FOLLOWING OPSONIN-INDEPENDENT 
ADHERENCE OF LEGIONELLA PNEUMOPHILA TO U-937 CELLS.
(The work outlined in this section has been published in the following articles: 
Rodgers, F. G., and F. C. Gibson. 1993. Opsonin-independent adherence 
and intracellular development of Legionella pneumopNIa within Li- 
937 cells. Can. J. Microbiol. 39: 718-722.
Gibson, F. C., and F. G. Rodgers. 1993. Ultrastructure of the Adherence 
and Intracellular Replication of Legionella pneumophila in 
Macrophage-like U937 cells. In: Barbaree, Breiman, and Dufour: 
Legionella: Current Status and Emerging Perspectives. ASM. 
Washington D.C. pp. 115-118.)
2.1 Abstract
Legionella pneumophila is an opportunistic bacterial pathogen that 
infects alveolar macrophages in the human lung during the initial stages of 
disease. To define the interactions of this organism with human alveolar 
macrophages requires the use of cell models to mimic alveolar 
macrophages; cells which are difficult to  obtain in a healthy state. As a 
consequence, many cell types have been used to simulate the interaction
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of L pneumophila with alveolar macrophages. The U-937 cell, a 
transformed human macrophage-like cell line, has been shown to  support 
the growth of L. pneumophila. In some ways these cells are similar to 
alveolar macrophages in that they express complement and Fc receptors 
and in this respect they may be more representative of macrophages for 
the study of Legionella attachment and growth than many other cell 
models thus far described. Observations to elucidate the initial interactions 
of this pathogen with human cells identified a complement-dependent 
system for describing Legionella attachment to monocytes. It has been 
proposed that an alternative attachment mechanism occurs for L. 
pneumophila and that this binding process is effected independent of 
serum factor influences. The growth kinetics and stages of cell infection 
involving this opsonin-independent system as verified by electron 
microscopy have been characterized and are similar to those process 
described following complement-mediated attachment. Cellular and 
ultrastructural studies indicated that legionellae bound to  U-937 cells within 
1 h and replicated rapidly over a 30 h period within ribosome-lined 
phagosomes in association with mitochondria and endoplasmic reticulum. 
Release of organisms from infected cells occurred by lysis which 
commenced approximately 30 h after infection. This work establishes the 




Legionella pneumopNIa is an intracellular bacterial pathogen that is 
the etiologic agent of a severe form of life-threatening lobar pneumonia. 
Approximately six months after the Philadelphia epidemic McDade et al.
(155) demonstrated that the causative agent of this outbreak was a 
previously unidentified bacterium that was found in biopsied lung tissue by 
light microscopy. Subsequently, Rodgers et al. (146) demonstrated by 
electron microscopy that L. pneumophila functioned as a facultative 
intracellular pathogen replicating inside host lung cells. The intracellular 
nature of the Legionnaires' disease bacterium is critical for the 
establishment of disease in humans. Furthermore, it aids organism survival 
by facilitating the evasion of the immune defence mechanisms of the host. 
Since the early 1980's studies have endeavored to elucidate the infectious 
process of L pneumophila within host cells (75,87, 111,132, 136, 152). As a 
number o f studies have shown, defining infection of host at the cellular 
level as well as understanding the interaction between the organism and 
the immune system of the host have proved problematic. Although, the 
general stages of Legionella infection, at the cellular and systemic levels, 
have been identified and a clearer picture of the pathogenesis of 
Legionnaires' disease has evolved, much remains to be elucidated on the 
nature and role o f bacterial virulence factors as well as host-mediated 
responses.
Legionellae are environmental organisms and are ubiquitous in 
freshwater habitats. While in these aquatic environments, L. pneumophila
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has a close relationship with phagocytic amoebae. Legionellae parasitize 
these cells and the resultant intracellular replication and release of 
bacterial progeny perpetuates these organisms in the aquatic 
environment. Preliminary investigations outlining Legionello-amoeba cell 
interactions were described in 1980 (146). Since then several studies have 
identified many host cells that support the intracellular replication of L 
pneumophila (57,120,128). It is commonly believed that human disease is 
coincidental and offers no ecological advantage to  the organism. These 
bacteria when presented in aerosolized form are taken up by the host and 
preferentially infect alveolar macrophages which, it is postulated, are 
infected in a fashion similar to amoebae in the environment. Several useful 
models for describing L. pneumophila interaction with protozoa have been 
reported (59,131). The stages of protozoal infection are very similar to 
those observed with human cells and include such important processes as 
ribosome-lining of phagosomes containing organisms, as well as similar 
intracellular replication kinetics (120).
In human disease, the alveolar macrophage is the target cell for 
Legionella infection. Due to the inaccessibility and unavailability of human 
alveolar macrophages, a suitable cell model simulating alveolar 
macrophages was required. A wide variety of cells have been used to 
study Legionella/host cell interactions and the ultrastructural development 
of intracellular Legionella and these include MRC-5, Vero, HEp-2 , HL-60 and 
U-937 as well as primary explants of human peripheral blood monocytes 
and human, guinea pig and simian alveolar macrophages (50,75,99,111,
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136,152). None of these cells is ideal in that each only approximates some 
of the normal activities of human alveolar macrophages in vivo.
Initial work centered on the role of the immune response of the host 
to this pathogen and as a consequence, a complement-mediated 
receptor binding mechanism was outlined (12,128,188). Recently, a novel 
attachment process for this organism has been suggested that occurs 
independent of serum influences (75,76,152). Host cell recognition is 
followed by attachment of the bacteria to  surfaces that possess 
appropriate receptors. Direct binding of bacteria to host cells have been 
described for group B streptococci and Yersinia pseudotuberculosis (4,92, 
93). Furthermore, recent work studying uptake of bacteria by phagocytes 
demonstrated that the mode of attachment (complement/antibody or 
direct binding) affected the subsequent intracellular fate of the organisms 
(187). It is possible that opsonin-independent binding mechanisms are 
necessary for intracellular infection to develop and that this may play an 
important role in the maintenance of disease.
2.3 Materials and Methods
2.3.1 Organism Cultivation: L pneumophila serogroup 1. strain Nottingham 
7 is a highly virulent clinical isolate from a fatal case of Legionnaires' 
disease. Initially the organism was isolated from sputum on low sodium, 
enriched, blood agar. Colonies were sub-cultured once onto buffered 
charcoal yeast extract agar supplemented with a-ketoglutarate (BCYE-a)
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(Difco, Detroit, Ml) and stored as stock cultures frozen at -70°C in 1% serum 
sorbitol (Appendix 1). Thawed aliquots were passaged once for 72 h on 
BCYE-a at 37°C in a humid atmosphere with added CO2 prior to 
experiments. Colonies were harvested and resuspended in buffered yeast 
extract broth containing a-ketoglutarate (BYE-a) to give 58 Klett units 
(equivalent to 1-2x108 colony forming units/ml). Tubes containing 5 ml 
sterile BYE-a were inoculated with 100 nl of this 58 Klett unit suspension and
were grow for 24 h at 37°C with vigorous shaking. Following growth, 1ml 
samples were placed into eppendorf tubes and centrifuged a t 8 XXX) x g 
for 15 min in a Beckman microfuge 12. Supemates were drawn off and 
p>ellets were resuspended in 1 ml sterile Hank's balanced salt solution 
(HBSS). This process was repeated 3 times and the organism containing 
samples were resuspended with fresh HBSS prior to infection assays.
Periodic assessment of Legionella virulence using the fertile hens' 
egg assay (Fig. 2.1) was conducted during the course of these studies to 
ensure that organism virulence was maintained (176).
2.3.2 U-937 cell Cultivation: U-937 cells were grown in RPMI-1640 cell 
culture media (Sigma, St. Louis, MO.) supplemented with 10% fetal bovine 
serum (FBS) in T-75 cm2 cell culture flasks (Costar, Cambridge, MA.) at 37°C 
with 5% CO2. Cells were grown to a density of 1-2 x 106 cells/ml, harvested 
by centrifugation at 250 x g for 10 min in 50 ml conical tubes (VWR 

















Figure 2.1: Diagrammatic representation illustrating the 
compartmentalization of the fertile hens' egg. The yolk sac route of 
inoculation was used to monitor virulence of L pneumophila in this model 
(176).
49
to give 5 x 105 viable cells/ml in 20 ml of fresh RPMI-1640 with 10% FBS. 
Differentiation of the U-937 cell to the macrophage-like status was done by 
adding 25 1^ of a 10-5 M solution of phorbol myristate acetate (PMA) to 
these cultures for 24 h. Adherent cells were washed 3 times with HBSS, 
physically removed from the culture flasks by gentle scraping with a silicon 
rubber-coated glass rod and harvested by centrifugation a t 250 x g for 15 
min. Collected cells were resuspended in fresh RPMI-1640 with serum at 5 x 
105 cells/ml and aliquoted into either T-75 cm2 flasks (20 ml) for thin section 
transmission electron microscopy (TEM), 6 well plates (3 ml) each containing 
a 22 mrr>2 glass coverslip for scanning electron microscopy (SEM) or 24 well 
plates (1ml) for viable bacterial cell colony (VBCC) counts studies cells 
were allowed to readhere in culture vessels for 24 h.
2.3.3 Infection Assay
U-937 cells were inoculated with L, pneumophila at a multiplicity of 
infection (MOD of 100 bacteria per host cell at 37°C for 1 h in fresh HBSS 
within an atmosphere containing 5% CO2. After the infection period 
monolayers were washed 3 times with HBSS. At this stage, fresh RPMI-1640 
medium with serum was added to each sample. Samples were collected 
at 1,6,12,24,48 and 72 h post infection. For TEM and SEM, infected 
monolayers were washed 3 times with cacodylate buffer containing lOmM 
MgSCXr pH 7.4 (CB), fixed for 18 h in 2% (v/v) glutaraldehyde (Electron 
Microscopy Science, Ft. Washington, PA) in CB and washed 10 times with 
CB in situ.
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2.3.4 Viable Bacterial Cell Colony Count: In conjunction with electron 
microscopic investigations of the attachment, intracellular replication and 
release events of L. pneumopNIa infection of U-937 cells, VBCC counts 
studies were performed to assess the rate of cell infection and intracellular 
replication of this organism. Following the 1 h infection of U-937 cells, 
supernotes were removed and each well was washed three times with 
HBSS to remove unbound bacteria. The three washings along with the 
supernotes were collected and pooled for each sample time. Serial 10- 
fold dilutions of these pooled samples were made in 1% (w/v) peptone and 
duplicate samples of 25 1^ were plated on BCYE-a agar for colony counting 
evaluations.
At each of the prescribed time intervals, cultures were assessed for 
both intracellular as well as extracellular bacteria. Following collection of 
supernatant fluids together with each of the 3 x 1 ml HBSS washings, the 
cells in each well were lysed by adding 1 ml sterile Milli-Q water for 30 min. 
The cells were then physically disrupted with vigorous aspiration and 
expulsion using a sterile pasteur pipette. For each time interval, a 100 pJ 
aliquot was removed from each of the supernatant fluids plus wash 
samples as well as each lysate. These samples were each 10-fold serially 
diluted in 1% (w/v) peptone and duplicate 25 nl samples were plated on 
BCYE-a agar for the enumeration of intracellular and released legionellae.
2.3.5 Transmission Electron Microscopy: For TEM, glutaraldehyde-fixed U-
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937 cells in CB were physically removed from the T-75 cm2 culture flasks 
with the aid of a silicone rubber-coated glass rod and harvested by 
centrifugation a t 200 x g in a Beckman model TJ-6 centrifuge. Samples 
were pre-embedded in molten 1% (w/v) Noble agar maintained at 55°C. 
The agar embedded specimens were allowed to  set at room temperature, 
were cut into 1 mm3 blocks and post-fixed in 1% (w/v) osmium tetroxide 
(OSO4) in CB for 24 h. Samples were then dehydrated in an ethanol series in 
CB consisting of 50%, 70%, 75%, 90%. and 95% for 5 min each and then into 
two changes of absolute ethanol for 10 min each. Samples were 
equilibrated in two changes, 10 min in propylene oxide (epoxy propane) 
and embedded in an epon-aryldite resin mixture (Appendix 2). At no time 
were samples allowed to dry. After polymerization at 60°C for 24 h, blocks 
were sectioned on a LKB ultramicrotome III using a diamond knife. Sections 
of 60-90 nm thickness were collected onto 400 mesh copper grids 
(Electron Microscopy Science), were stained with 1% (w/v) uranyl acetate 
for 1 min. and 0.4% (w/v) lead citrate for 30 sec. and examined in a Hitachi 
H-600 scanning-transmission electron microscope at 75 kV in the 
transmission mode.
2.3.6 Scanning Electron Microscopy: For SEM, glutaraldehyde-fixed 
samples were washed thoroughly with PBS at pH 7.2 and dehydrated in a 
graded ethanol series to absolute ethanol. Specimens were fully dried 
from hexamethyldisalizane (EMS, Fort Washington, PA) in air. Monolayers on 
coverslips thus dried were sputter coated with 20 nm gold-palladium in a
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Hummer V sputter coater with a specimen to target distance of 5 cm for 4 
min at 15 mA and observed in an AMR 1000 scanning electron microscope 
at60 kV.
2.4 Results
The virulence of the stock cultures of this strain remained unchanged 
from previous studies (176). Adherence of L. pneumophila to  U-937 cells in 
the absence of opsonins was observed within the 1 h incubation period 
(Fig. 2.2). By comparison with normal control (uninoculated) U-937 cells (Fig. 
2.3), analysis of the 1 h post-inoculation specimens by TEM showed that 
wash-resistant attachment involved apposition of L pneumophila 
membrane blebs and host cell surface membranes (Fig 2.4). SEM 
observations of similar monolayers showed numerous legionellae adherent 
to  U-937 cells. In addition, SEM data suggested that little host cell change 
occurred following these initial adherence steps of virulent bacteria to host 
cells (Fig. 2.5). VBCC counts data indicated that approximately 1x10* 
bacteria had attached to 5 x 105 U-937 cells. From this it was clear that 
approximately 2 bacteria had bound to each U-937 cell in the monolayers 
and this constituted 2% of the initial inoculum (Fig. 2.2). Neither coiling 
phagocytosis (83) nor the presence of banded enclosures (Oldham and 
Rodgers) previously reported for human monocytes and other cells were 
observed; however, these differences may have reflected the absence of 
opsonic components in the adherence medium in the present study.
Rapid intracellular bacterial multiplication was observed (Fig 2.2).
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Figure 2.2: Attachment and intracellular replication of L pneumophila 
N7 in U-937 cells measured by VBCC counts. U-937 cells at 5x10 
cells/ml were infected with a MOI Of 100 L. pneumophila and washed 1 
h after infection. Intracellular replication ( O - O  ancl Cleese ( # —0 )  
of legionellae. Assays were the average of three trials and bars 
represent standard error.
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Control U-937 cells SEM and TEM
Plate 2.3: Untreated U-937 cells observed by transmission electron 
microscopy (A) and scanning electron microscopy (B). Magnification A = 
x 17,(XX); B = x 3000. Bars: A = 2 jim  and B = 10 jim.
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1 h U-937 Cells TEM with inset high magnification
Plate 2.4: L. pneumophila bound to a U-937 cell 1 hr after infection. Inset: 
higher magnification of host cell-bacterium interaction. Note electron 
lucent zone between organism and cell. Magnifications A = x 17,000; B = 
x 60,000. Bars: A = 2 pm and B = 300 nm.
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1 h U-937 cells SEM
Plate 2.5: L pneumophila bound to U-937 cell at 1 hr after infection by SEM. 
Note several bacteria bound to the surface of the host cell. Magnification 
= x 5000. Bar represents 5 jim.
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Plate 2.6: TEM (A) and SEM (B) of L pneumophila 12 hr after infection of LI- 
937 cells. Organisms are contained within loose phagosomes which are 
ribosome-lined. Effects of infection on host cells include blunting and a 
decrease in the number of microvilli on the surface of U-937 cells. 
Magnification: A = x 20,000; B = x 3000. Bars: A = 3 nm and B = 10 pm.
24 h U-937 cells SEM and TEM
Plate 2.7: TEM (A) and SEM (B) of L pneumophila 24 hr after infection of LI- 
937 cells. TEM of organism infected U-937 cell. Note fulminant infection of 
cell as well as the release of organisms from the phagosome. B. SEM of 
infected cells. Cells are rounded and show a decrease in the number of 
microvilli which show marked blunting. Magnification: A = x 13,600; B = 
x 3000. Bars: A = 2 |im and B = 10 nm.
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46 h U-937 cells SEM and TEM
Plate 2.8: TEM (A) and SEM (B) of L. pneumophila 48 hr after infection of LI- 
937 cells. TEM of organism infected U-937 cell. Note bacteria no longer 
confined to phagosomes and some bacteria can be seen in the 
extracellular milieu. B. SEM shows almost complete loss of microvilli. 
Magnification: A = x 25,500; B = x 3000. Bars: A = 2 |im and B = 10 p.m.
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72 h U-937 cells SEM and TEM
Plate 2.9: TEM (A) and SEM (B) of L pneumophila 72 hr after infection of LI- 
937 cells. Host cells are seen at the terminal stages of infection. Cell lysis 
and lack of bacteria within cells are noted in both TEM and SEM 
presentations. Magnification: A = x 13,600; B = x 2000. Bars: A  = 2 nmand 
B = 10 |im.
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Intracellular bacterial replication, which occurred by pinching binary fission, 
was evident by 12 h post-infection of cell monolayers (Fig 2.6). Legionella 
replication occurred initially in tight, ribosomes lined vacuoles and later 
these phagosomes were much distended. Host cells at this time possessed 
fewer microvilli at the surfaces. By 24 h post infection, intracellular L. 
pneumophila were confined to loose vacuoles within the U-937 cell (Fig. 
2.7). At this stage of the infectious process, cytoplasmic clearing was 
evident and extensive intracellular damage was also noted. Continued 
loss and blunting of microvilli were apparent as the infectious process 
continued. Gross morphologic surface changes were evident by 48 h 
post-infection and these included cell lysis with a concomitant increase in 
cellular debris as was evident by TEM and SEM (Rg 2.8). Although bacteria 
were observed within cells at 48 h post-infection they were present within 
disrupted vacuoles. At this stage of the infectious process the integrity of 
the plasma membrane was breached in numerous cells and released 
bacteria predominated. By 72 h cellular infection and disruption was 
complete with >95% of the U-937 cells detached and lysed (Fig. 2.9). VBCC 
counts of washed samples (extracellular organisms) and U-937 cell lysates 
(intracellular organisms) showed maximal intracellular Legionella numbers 
by 24 h of infection (Fig 2.2). As intracellular replication continued toward 
the later stages of infection (72 h) an increase in the number of bacteria 
was found in the extracellular milieu with a simultaneous decrease in the 
number of intracellular organisms. In addition, L. pneumopNIa did not 
replicate in either HBSS or RPMI-1640 with or without added FBS, whether
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previously conditioned with U-937 cells or not.
2.5 Discussion and Conclusions
Legionella pneumophila infections constitute a significant source of 
medical problems each year and an understanding of the infectious 
process at the cellular level is essential prior to the potential development 
of vaccines for the control of this pathogen. Investigations of biopsied 
lung tissue strongly suggested the alveolar macrophage as the most likely 
candidate for the establishment of human disease (183). Although cell 
models have been proposed to mimic human alveolar macrophage 
infection at the cellular level these cells are generally difficult to obtain. 
Horwitz and Silverstein (88) initially described the interaction of L. 
pneumophila with human peripheral blood monocytes and since then 
many cells have been shown to support intracellular replication of the 
Legionnaires' disease bacterium (75, 111, 128,134,138,152). Although the 
organism has been shown to replicate within epithelial, fibroblast and 
mononuclear cells; they appear to be incapable of replication within 
PMNLs (62, 88, 134).
Several transformed cells have been proposed as potential cell models the 
HL-60 cell which expresses polymorphonuclear leukocyte-like or 
macrophage-like characteristics and the U-937 cell, a histiocytic lymphoma 
cell line which can express either monocyte or macrophage-like cell 
surface markers (170). The U-937 cell has been used frequently as a model 
cell to  represent Legionella-host cell interactions (111, 138). Peariman et al.
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(138) demonstrated that L pneumophila could infect the transformed 
human histiocytic lymphoma cell line U-937. These studies suggested that 
U-937 cells may be an appropriate model for reliable investigations of the 
Legionella/host cell interactions. The inducible dual monocytic and 
macrophage-like nature of these cells, which is dependent on cell 
differentiation, makes them amendable to studies of L pneumophila 
interactions with monocyte-like and macrophage-like cells. In vitro , U-937 
cells are monocyte-like; however, they can be differentiated into 
macrophage-like cells when stimulated with agents such as phorbol 
myristate acetate (PMA), gamma interferon (IFN^y), 1a,-dihydroxyvitamin
D3 (a vitamin D metabolite), human recombinant interleukin-6 , or retenoic 
acid (143, 161). In the undifferentiated state, U-937 cells are non-adherent 
and have the ability to divide in culture. However, when differentiated, 
these cells possess receptors analogous to macrophages, adhere to 
culture vessels, and are incapable of cell replication. In addition, the U-937 
cell has been studied extensively in order to determine the role of the 
macrophage in infection and to elucidate features of cell mediated 
immunity (34,61, 142). These cells express both high and tow Ig G binding 
receptors as well as the complement receptors type 3 (CR3) and type 4 
(CR4) at levels similar to alveolar macrophages (63,110,159,161). 
Furthermore, the U-937 cell is rapidly becoming the cell of choice to study 
host-microbe interactions and in investigations to better understand the 
effects of modulation of the human immune system. U-937 ceils have also
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been used extensively to study the production and expression of proteins 
by intracellular pathogens such as Salmonella typhi and L pneumophila 
when these organisms are wtthin host cells (2,101). This cell is considered a 
versatile model in the areas of immunology, pathogenesis and 
microbiology (110,115, 138,141).
Attachment is the first interaction to occur between a facultative 
intracellular bacterial pathogen and its appropriate host cell (11). Many 
adherence mechanisms and the structures involved have been 
elucidated for a variety of prokaryotes and their eukaryotic host cells (49, 
92). Bacterial adherence of an organism to a host cell is believed to be a 
two stage phenomenon in which an initial weak association occurs, 
mediated by forces such as electrostatic, van der Waals and hydrophobic 
interactions, and these are followed by a second, much stronger binding 
event. Attachment of legionellae to human monocytes was initially shown 
to be dependent on the deposition of complement on the Legionella 
MOMP (12). This organism adheres to and infect cells which are not 
professionally phagocytic such as fibroblastic MRC-5 cells, and the 
epithelial HEp-2 and Vero cells (134). Since these cells do not possess 
complement and Fc receptors normally found on the surface of 
mononuclear cells, it is not clear how they become colonized and support 
infection of the organism. Furthermore, colonization and intracellular 
infection of fresh water amoebae clearly occurs in nature in the absence 
of opsonic components (8). In addition to the broad range of cells that are 
parasitized by L. pneumophila, work by Reynolds and Newbold (145)
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demonstrated that the distal bronchioles and the alveolar spaces of the 
human lung typically contain very low levels of complement. Therefore, the 
opsonin-independent system of binding may prove an important 
mechanism for the initial recognition events of L pneumophila and alveolar 
macrophages. Studies to better define these alternative processes are 
necessary.
Uptake studies conducted in media containing complement 
components showed that Legionella entered host cells by a process 
defined as coiling phagocytosis (83). Oldham and Rodgers (134) noted 
organism uptake by host cells occurred within banded enclosures. These 
were not observed in the present experiments conducted in the absence 
of serum. Recently, Horwitz (85) has indicated that when uptake studies are 
conducted in the presence of complement, coiling phagocytosis occurs 
for many Legionella species; however, it was noted that not all bacteria in 
a population are taken up in this fashion. This variation may indicate 
organism-based differences or may represent two mechanisms of 
organism uptake are occurring simultaneously. The present studies 
suggest that uptake under opsonin-independent conditions does not 
occur via coiling phagocytosis. Other studies addressing Legionella uptake 
have described a 24 kD macrophage infectivity potentiator or MIP protein 
as a necessary factor for L. pneumophila uptake by phagocytic cells (31, 
51). Yet it is clear that this protein plays no role in the adherence process of 
Legionella to  macrophages. Isogenic mutants of L pneumophila devoid of 
the MIP protein, binds to host cells, but are not taken-up (29).
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Following uptake of L. pneumophila by monocytes or other cell 
types, the organism is contained within tight-fitting phagosomes. The 
recruitment of both ribosomes and mitochondria occurs and this 
recruitment event appears to be necessary for intracellular replication (87, 
134). it is not understood why this organelle recruitment should occur; 
however, it may be an important factor for organism survival within host 
cells, or may be involved in the supply of nutrients to the organism. 
Intracellular survival with subsequent multiplication of Legionella was 
apparently dependent on the ability of the organism to  uncouple both the 
acidification of the phagosomes as well as prevent lysosome fusion with 
bacteria-containing phagosomes in the macrophage (86). Inhibition of 
phagosome-lysosome fusion was a crucial factor in the persistence and 
subsequent intracellular replication of legionellae in host cells. The later 
stages o f U-937 cell infection occurred from 48-72 h after infection as 
documented within these cells and demonstrated phagosome distention 
with a concomitant increase in the number of bacteria within these 
structures. Fulminant cellular infection was followed by bacterial escape 
into the cytoplasm of the host cell. Subsequent to this event, release of L. 
pneumophila occurred into the extracellular milieu following lysis of the 
cells. The factors governing the process of cell escape is not known, 
however the L pneumophila protease, the major secretory protein of the 
organism may be central to bacterial release from the phagosome and 
final escape from terminally infected host cells.
This study adds further to the suggestion that opsonin-independent
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processes may be necessary for the initial establishment of macrophage 
infection and that complement mediated processes could follow as 
cellular destruction and local inflammation proceed (91). This idea may be 
important as it has been shown that L. pneumophila can bind to a cells in 
the absence of serum (75,152). In the absence of specific antibody, 
complement did not promote the adherence of L pneumophila to U-937 
cells, guinea pig alveolar macrophages or J774 mouse macrophages (91). 
The present work taken together with that of Husman and Johnson (91) 
indicate that an opsonin-independent attachment mechanism may exist 
for Legionella and the establishment of infection may be directly related to 
this process.
These experiments identified the attachment of L pneumophila in an 
opsonin-independent fashion and documented the morphological events 
of intracellular replication following Legionella infection of U-937 cells. In 
addition, this study supports the usefulness of U-937 cells as a model for 
macrophage infection in that the intracellular development of Legionella 
and the cell-induced changes were similar to those described for guinea 
pig alveolar macrophages and human peripheral blood monocytes. The 
use of these cells may further assist in clarifying the cellular and molecular 
events involved in the development of Legionnaires' disease (75,138,152).
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SECTION III
PARTIAL CHARACTERIZATION OF THE ADHERENCE OF LEGtONEUA
PNEUMOPHILA 
TO U-937 AND GUINEA PIG ALVEOLAR MACROPHAGES.
CThe work outlined in this section has been published in the following article: 
Gibson, III, F. C., F. G. Rodgers, and A. O. Tzianabos. 1993. Opsonin-
independent Adherence of Legionella pneumophila to MRC-5 and 
U937 cells. In Barbaree, Breiman and Dufour: Legionella: Current 
Status and Emerging Perspectives. ASM. Washington D.C. pp. 78- 
82.)
3.1 Abstract
Adherence of Legionella pneumophila, strain Nottingham N7, to host 
cells occurred in salt solutions devoid of opsonins. Two cell types. U-937 
cells and primary explants of guinea pig alveolar macrophages were used 
to study and partially define the opsonin-independent adherence 
mechanisms for L. pneumophila. ’ Adhesin' and ’ receptor" 
characterization studies were performed by assaying the numbers of 
Legionella organisms which had adhered to cells using viable bacterial cell 
colony (VBCC) counts and indirect immunofluorescent assays (IFA).
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Receptor saturation studies indicated that at a multiplicity of infection of 
100 2%-8% of the non-opsonized bacterial inoculum was taken-up following 
the addition of L. pneumophila to host cells. The single saturation plateau 
noted with VBCC counts and IFA suggested a first order kinetic relationship 
of one bacterial ‘ adhesin' per host cell ‘ receptor* for L. pneumophila to 
each of the 2 cell types studied. The binding structures were modified to 
determine the broad chemical make-up of the bacterial adhesins and host 
cell receptors in competitive binding assays. In addition, surface 
membrane treatments were performed to determine the interruption of 
binding due to the enzymatic loss or destruction of particular groups of 
molecules; a process of determining the nature of function, through loss of 
function. With the exception of the aldehydes, these treatments had no 
effect either on the viability of either the microorganism or the host cell. 
Adhesin evaluation was made using chemical treatments of the bacterial 
membrane surfaces and these studies indicated that the adhesin was a 
complex structure consisting of protein material with lectin-like or 
carbohydrate characteristics suggestive of a glycoprotein. However, the 
role of lipopolysaccharide could not be excluded. Modification of host cell 
membranes indicated that carbohydrate moieties suggestive of glycolipids 
on the host cell surface acted as receptors responsible for binding L 
pneumophila. However, the nature of these carbohydrate receptors 




Bacterial recognition of host cells by pathogens is a necessary event 
prior to the establishment of infection (11). The concept of bacterial 
adherence to  substrates is well described and many studies have 
demonstrated that bacteria bind efficiently either to particular substrates in 
the environment or to cells in host tissues (11.49,74). Work on the 
microflora of the mouth established microbial attachment-dependent 
colonization in humans by microbes and demonstrated the adherence of 
microorganisms to both tooth and mucosal surfaces (74). Other studies 
suggested that bacterial colonization was frequently dependent on a prior 
attachment or binding event (11). Some microorganisms bind to a variety 
of 'ine rt' or non-living substances and some have been shown to bind to 
eukaryotic cells while others possess the ability to do both (11,74). To 
define the interaction of a bacterium with a host cell, current terminology 
identifies the bacterial attachment structure as the 'adhesin' and the 
structure to  which the organism binds as the 'receptor' and attachment 
can occur to  epithelial cells, endothelial cells or macrophages. (40,87,92, 
134). Fimbriae and the glycocalyx of some bacteria are well-established as 
adhesins for several species of bacteria; however, structures such as outer 
membrane proteins and lipopolysaccharide are also frequently associated 
with adherence (11,49,91,133,187,188).
Attachment is a multifactorial event and is dependent on many 
factors including availability of appropriate receptors, spatial distribution of 
adhesin and receptor moieties, attractive and repulsive forces, physical
factors such as pH and flow rate and the degree of hydrophobicity of the 
interacting membranes (11,48) Moreover, the stages of binding usually 
involve a sequential two-step process in which a preliminary or weak 
binding event is followed by a firm highly specific attachment process. 
However, the presence or absence of these diverse bacterial structures 
are dependent on the phase of growth of the organism and for 
pathogens, the stage of the infectious process. One such process is phase 
variation of fimbrial expression.
A rapidly emerging hypothesis is that pathogens may possess several 
mechanisms by which they interact with a host cell either at different 
stages of the infectious process or when the participants interact in 
differing environments such redundancy has been demonstrated for 
Escherichia coli, Salmonella iyphi, Mycobacterium tuberculosis and 
Legionella pneumophila (12,60,75, 165). This concept may be an 
important feature either for determining the conditions necessary for the 
establishment of disease or as a microbial strategy for evading the immune 
response of the host (132, 165). Recently, it has been demonstrated that 
several pathogens take advantage of a series of immune system-specific 
receptors known as integrins and gain entry into various cells through these 
relatively conserved group of molecules (4,12,93,162). The integrins most
frequently utilized by microorganisms include the Pi and integrin subsets, 
while the majority of organisms which abuse these receptors are 
facultative intracellular pathogens (4,93,162). The Pi integrins are used by
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organisms that possess invasin on their surface, while the 02 group of
receptors including complement receptor type 3 (CR3) are exploited by 
organisms that bind directly to these cells either in the presence or in the 
absence of complement or immune modulators (4,39, 75,93, 152, 162).
Opsonins, such as complement and antibody, are phagocytosis- 
enhancing molecules and are well-recognized as facilitators for the 
destruction of foreign material by phagocytes. Components of the 
immune system of the host, specifically antibody and complement, are 
deposited on bacteria, thus facilitating the processing mechanism leading 
to engulfment by macrophages. In contrast, the mechanisms of direct 
recognition of bacteria by macrophages, independent of these 
modulators, is poorly understood at best (4, 11, 75,152). In addition, a role 
for opsonin-dependent bacterial attachment is well-established in the field 
of adherence. Direct bacteria-host cell binding in the absence of these 
immune mediators has established that direct attachment may be an 
important mechanism of recognition, especially for some facultative 
intracellular pathogens (75,94,152,162). L. pneumophila attachment to 
host cells, mediated by complement, has been shown while bacterial 
attachment between adhesin and host cell receptors may also occur. 
Candidate binding structures for L pneumophila include fimbriae, flagella, 
outer membrane proteins and lipopolysaccharides (148). The precise 
nature of microbial adherence is critical to understanding the mechanisms 
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Figure 3.2: Schematic defining the putative L.pneumophila adhesins and 
host cell receptors. (Reproduced from reference , Rodgers, Zbl Bakt. I Abt. 
Orig. A. 1983).
74
the manner in which bacteria bind to cells directly affects the fate of the 
organism in the host cell (178, 182,188).
L. pneumophila is the causal agent of Legionnaires' disease; a 
severe form of lobar pneumonia. This pathogen parasitizes a wide variety 
of mammalian cell types, as well as freshwater protozoa (59,75,87,111, 
122,134). In the environment the numbers of legionellae increase when 
protozoa are present (59). This amplification prior to colonization of water 
supplies and their aerosolization forms a necessary prelude to  the 
establishment of human infection. The inhalation of Legionella- 
contaminated aerosols into the lower respiratory tract (LRT) constitutes the 
initial stage of disease and once there, organisms infect alveolar 
macrophages (AM0). Legionella adheres to human derived cells including 
monocytes and macrophages in the presence of the serum opsonins 
complement or specific antibody (12,89,91). Although the guinea pig has 
been adopted as the model of human disease, an acceptable cell model 
for the study of legionellosishas not been forthcomming. Guinea pig 
alveolar macrophages (GAM), human peripheral monocytes, U-937 cells 
and HL-60 cells have been used to investigate bacteria/alveolar 
macrophage interactions; however, none are apparently ideal. U-937 cells 
were derived from a human histiocytic lymphoma (170) and these have 
been shown to exhibit macrophage-like characteristics such as Fc and 
CR3 expression following treatment with phorbol myristate acetate (PMA) 
(103,16,163,167). Pearlman et al. (138) documented uptake and survival 
of virulent legionellae within U-937 cells in the presence of serum.
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Previous work centered on the role of complement and specific 
antibody-mediated uptake of this facultative intracellular pathogen (12,89, 
91). Legionella attachment to peripheral blood monocytes and 
macrophages involves the deposition of complement 3b (C3b) on the 
bacterial major outer membrane protein (MOMP) of Legionella (12). 
Opsonized bacteria are then recognized by host cell complement 
receptors. Following opsonin-mediated attachment, legionellae are 
apparently taken-up by a novel coiling phagocytotic process (83).
It is possible that uptake of L. pneumophila by host cells may not use 
an opsonin-dependent mechanism in the initial stage of infection (75, 152). 
The rationale for this is based on the observation that respiratory secretions 
and the environment of the normal human lung are tow in opsonins (145).
In the light of these observations opsonin-independent adherence 
mechanisms for microbial attachment were investigated and attempts 
were made to identify and characterize the adhesins and receptors in the 
binding process.
3.3 Materials and Methods
3.3.1 Bacterial Growth and Maintenance
L. pneumophila strain Nottingham N7 was grown and maintained as 
previously described (see Section 2.3.1).
3.3.2 Cultivation of U-937 cells
U-937 cells were grown and phorbol ester treated as previously
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described (see Section 2.3.2).
3.3.3 Collection and Cultivation of Guinea pig Alveolar Macrophages
Hartley outbread guinea pigs of 600-650 g (Charles River Labs, 
Willmington Mass.) were euthanized with an intraperitoneal injection of 
sodium pentobarbitol. The animals were then bled by lacerating the dorsal 
aorta prior to the collection of macrophages. Alveolar lavage was 
performed with intratracheal injection of 10ml sterile HBSS (pH 7.2) from a 
syringe through an 18-gauge needle followed by aspiration of the HBSS- 
macrophage suspension (Appendix 3). Lavage was repeated 4 times per 
guinea pig and this yielded approximate 5 x 106 macrophages per animal. 
GAM cells were held on ice prior to enumeration. Cells were placed in 50 
ml conical centrifuge tubes, centrifuged at 250 x g, counted in an 
American Optical hemocytometer and resuspended in RPMI-1640 medium 
containing 10% FBS (Appendix 2) to yield 2.5 x 105 cells/ml. Macrophages 
were then distributed to 6 or 24 well cell culture plates and allowed to 
adhere for 2h in a humid environment at 37°C in 5% CO2 prior to use.
3.3.4 Treatments
All treatment were prepared fresh in HBSS, adjusted to pH 7.2 and 
filter sterilized through a 0.22 urn pore-size filter prior to use.
Concentrations, treatment times and the rationale for cell-surface 




Monolayers of U-937 cells or guinea pig alveolar macrophages in 
each 6 or 24 well plates were washed 4 times with HBSS to remove serum 
opsonins from the culture media and fresh HBSS without serum was added. 
The cells were then inoculated with L pneumopNIa N7 at a MOI of 100. For 
competitive binding studies sugars were added to cells in each well 10 min 
prior to the addition of organisms. Surface modification of either the 
prokaryotic or eukaryotic cells was done prior to  adding organisms to host 
cells. Following each treatment regime, legionellae were allowed to 
adhere for 1 h. Monolayers were then washed 3 times with HBSS to remove 
non-adherent bacteria. Adherence was assayed by VBCC counts and IFA 
and the data was compared with untreated controls.
3.3.6 Detection: Viable Bacterial Cell Colony Counts
Inoculated monolayers in 24-well culture plates were lysed at room 
temperature by adding to each 1ml sterile distilled water for 30 min 
followed by vigorous aspiration with a sterile pasteur pipette. The resultant 
lysates were serially 10-fold diluted in 1% peptone and 25 *il of each dilution 
was plated in duplicate on BCYE-a agar. Colonies were counted at 72 h 
and the number of bacteria in each origional sample was evaluated.
3.3.7 Detection: Immunofluorescent Assay
Prior to adding U-937 or GAM cells to 6-well cell culture plates, 22
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Competitive binding Treatments
Table 3.1: Competitive Binding Experiments*
AGENT* CONCENTRATION FUNCTION
N-acetyl-D-glucosamine (NAc Glu) lOOmM
N-acetylgalactosamine (NAc Gal) lOOmM
N-acetylneuraminic acid (NAc Neu) lOOmM Competitive
















Lipase 100.0 30 Degrades
Neuraminidase 1.0 30 sensitive receptor




Glutaraldehyde 0 .1% 10 Immobilization of
Formaldehyde 1.0% 10 protein moieties
Nonidet P40 0.005% 60 Oxidation of lipids
Sodium 5mM 10 Oxidation of
metaperiodate carbohydrates






100ng/ml 60 Binds to mannose
Agglutinin
(WGA)











B-galactosidase 100 60 Degradation of
Chymotrypsin 250 60 protein/sugar
Lipase 100 60 containing
Neuraminidase 20 60 moieties on the
Protease 5 60 surface of L
Trypsin 250 60 pneumophila
Fixative
Glutaraldehyde 0 .1% 10 Immobilization
of protein moieties
Oxidizing Agent




mm2 sterile glass coverslips were added and the cells were allowed to 
adhere to  the coverslips. After competitive binding and prokaryotic or 
eukaryotic cell surface treatments had been performed, monolayers were 
inoculated with L. pneumophila as described in the infection assay (3.3.4).
After 1 h incubation, host cells were washed 3 times to remove 
unbound bacteria after which cultures were fixed with 10% formalin in PBS 
(pH 7.2) for 1 h at 25°C. After three further washings with PBS, monolayers 
were treated with rabbit polyclonal L pneumophila strain N7 antiserum for 
1 h at 37°C. Unbound globulin was removed by washing 3 times with PBS 
and goat anti-rabbit FITC conjugated antibody (Boehringer Mannheim, 
Indianapolis, IN) was added for 1 h. After multiple washings with PBS to 
remove unbound globulin, cells were counter-stained with 0 .01% propidium 
iodide in PBS for 30 min and were further washed three times with PBS. Cells 
on coverslips were air-dried and mounted in glycerol containing 1% 1A- 
diazobicycto (2.2.2) octane (DABCO) (Sigma) as a anti-quenching agent.
3.3.8 Detection: Criteria for Assessing Data
VBCC counts were an average of 10 trials, each performed in 
duplicate and the number of bacteria bound either to control host cells or 
to cells following the various treatment regines were calculated as colony 
forming units (cfu). Adherence was expressed as a percentage of control 
cells. VBCC count data were statistically analized by determining standard 
error using Statview software package (Abacus Concepts) on a Macintosh 
Cetris 610 microcomputer. IFA results were the average of 3 trials
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enumerating adherent bacteria on the first 200 cells observed per trial. 
Data were calculated as the number of bacteria bound to each host cell 
and expressed as a percentage of control cells. A 50% change in 
adherence data was the criterion used to assess significance of a 
particular treatment for both VBCC counts and IFA studies.
3.3.9 Binding Kinetics
Wells containing U-937 cells (5 x 105 cells/ml) or GAM cells (2.5 x 105 
cells/ml) in either 6 or 24 well cell culture plates were washed 5 times with 
HBSS to  remove serum contained opsonins. Fresh HBSS was added to each 
well containing cell monolayers and these monolayers were infected with 
increasing 10-fold multiplicities of infection (MOI) of L pneumophila 
organisms. Following a 1 h incubation period a t 37°C, unbound bacteria 
were removed by multiple HBSS washings. Infected cell monolayers were 
then processed for VBCC counts or IFA detection respectively.
3.4 Results
Saturation kinetics for U-937 and GAM cells indicated that host cell 
receptor saturation was effected at the equivalent of 1000 bacteria per 
host cell or 2-5 x 108 bacteria added to 2-5 x 105 host cells. These findings 
were similar for each cell type and assay method (Fig. 3.2.3.3.3.4,3.5).
Due to  unacceptible levels of non-specific binding to the plastic culture 
plates at receptor saturation a MOI of 100 was selected for all subsequent 
studies. This gave an inoculum size close to receptor saturation levels and
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minimized non-specificity while retaining the effectivness of 50% or greater 
changes in binding data.
Following, a 1 h incubation with a 100 MOI of virulent L. pneumophila, 
host cells bound approximately 2% to 8% of the bacterial inoculum as 
indicated both by VBCC counts and IFA (see Fig. 3.2,3.3,3.4,3.5).
3.4.1 Competitive Binding Treatments
Co-incubation of L pneumophila with host cells in the presence of 
monosaccharides in a competitive fashion indicated that none of the 
tested simple sugars outlined in Table 3.1 inhibited opsonin-independent 
attachment. Similar data was generated by VBCC and IFA counts (Fig. 3.6, 
3.7,3.8,3.9). However, carbohydrate oxidation by sodium metaperiodate 
treatment of either the organism or host cells indicated the importance for 
carbohydrates, other than those tested, in the attachment of Legionella to 
GAM cells.
3.4.2 Host Cell Surface Modification
In an effort to  determine the general chemical moiety of the host 
cell receptor used by L. pneumophila to  attach to  host cells, cell surface 
membranes were chemically treated to digest or remove potential 
receptors. These studies indicated that U-937 and GAM cells possessed 
somewhat similar profiles for their adherence to receptors (Fig. 3.10, 3.11,
3.12.3.13) treatments outlined in Table 3.2. The receptor structure was 
apparently carbohydrate in nature with likely lipid components (Fig 3.18).
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Metaperiodate oxidation of saccharides on the surfaces of host cells 
strongly inhibited bacterial attachment and was suggestive of 
carbohydrates in the receptor complex. Likewise, lipids may be involved 
with adhesin recognition as Nonidet P40 solubilization of lipids slightly 
interfered with the binding of legionellae to U-937 and GAM cells while lipid 
cleavage by lipase treatment gave variable results. Host cell surface 
proteins modified by trypsin, chymotrypsin protease or pepsin did not 
significantly influence the adherence of the organism to  these cells. In 
addition, neuraminidase did not abolish adherence suggesting no role for 
neuraminic acid residues in binding. The addition of the lectins wheat germ 
agglutinin (WGA) or concanavalin A (Con A) strongly interupted 
attachment, supporting a role for lectins or lectin-like molecules on the 
bacterial surface as required for the attachment event. WGA has binding 
specificity for N-acetyl-glucosamine and neuraminic acid while Con A 
attaches to mannose residues. These data suggested an inhibitory effect 
would be expexted for these saccharides tested in competitive binding 
experiments; however, this was not the case.
Inhibition of microtubule formation by pretreating host cells with 
cytochalasin B, thus uncoupling the processes of organism attachment 
from organism uptake, showed no effect on bacterial binding. Treatments 
of host cell surfaces indicated essentially similar receptor profiles; however, 
some differences were noted between these cell types. With the 
exception of the aldehyde fixatives, the host cell treatments did not 
significantly affect host cell viability.
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3.4.3 Bacterial Surface Treatment
Adhesin modification studies performed using the treatments 
outlined in Table 3.3 indicated that a complex bacterial structure was 
involved in this opsonin-independent attachment process. All treatments 
with the exception of neuraminidase produced significant decreases in L 
pneumophila attachment to the host cells. From these data, the adhesin of 
L. pneumophila would seem most likely to be a protein containing 
carbohydrate and possibly lipid components (Fig. 3.14,3.15,3.16,3.17). The 
most likely structure is a glycoprotein located on the bacterial surface 
which interacts and binds to a glycolipid on the host cell membrane (Fig.
3.18) All of the protein modifying agents tested, trypsin, protease and 
chymotrypsin significantly reduced bacterial attachment. In addition, the 
data from the metaperiodate oxidation of organism surface indicated that 
carbohydrates were necessary for binding of Legionella to  both U-937 and 
GAM cells while lipase treatment moderately affected attachment. Noted 
that none of these adhesin modifying agents affected bacterial viability as 
determined by VBCC counts.
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Figure 3.2: Binding of L pneumophila to U-937 cells as measured by VBCC 
counts. U-937 cells were seeded at 5 x 105 cells/well and increasing 10-fold 
multiplicities of infection o f bacteria were added to the cells. Ratios of cfu 
per U-937 cell were determined by dividing the resultant lysate value by the 
number of host cells per well. Host cells approached saturation with L 
pneumophila with an inoculum of 5x 107 cfu/ml and this approximated 1.7 
bacteria per U-937 cell. Each point is the average of 3 trials.
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Figure 3.3: Binding of L pneumophila to U-937 cells as measured by IFA. U- 
937 cells were seeded at 1 x 10* cells/well and increasing 10-fold 
multiplicities of infection of bacteria were added to the cells. Each point is 
the average of 3 trials enumerating the total number of fluorescent 
bacteria bound to 200 host cells. Host cells approached saturation with L 
pneumophila with an inoculum of 1.5 x 108 cfu/m l and this approximated 3 
bacteria per U-937 cell.
88













Figure 3.4: Binding of L. pneumophila to guinea pig alveolar macrophages 
cells as measured by VBCC counts. Guinea pig alveolar macrophages 
were seeded at 2.5 x 105 cells/well and increasing 10-fold multiplicities of 
infection of bacteria were added to the cells. Ratios of cfu per guinea pig 
alveolar macrophage were determined by dividing the resultant lysate 
value by the number of host cells per well. Host cells approached 
saturation with L. pneumophila with an inoculum of 2.5 x 107 cfu/ml and this 
approximated bacteria per guinea pig alveolar macrophage. Each point 
is the average of 3 trials.
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Figure 3.5: Binding of L pneumophila to guinea pig alveolar macrophages 
as measured by IFA. Guinea pig alveolar macrophages were seeded at
7.5 x 105 cells/well and increasing 10-fold multiplicities of infection of 
bacteria were added to the cells. Each point is the average of 3 trials 
enumerating the total number of fluorescent bacteria bound to 200 host 
cells per trial. Host cells approached saturation with L pneumophila with an 
inoculum of 7.5 x 107 cfu/ml and this approximated bacteria per U-937 cell.
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Figure 3.6: Competitive inhibition of L pneumophila binding to U-937 cells 
as measured by VBCC counts. Each value represents the average of 10 
trials enumerating percent bacterial adherence of controls with co­
incubation of legionellae with the saccharides listed in Table 3.1.
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Figure 3.7: Competitive inhibition of L. pneumophila binding to U-937 cells 
as measured by IFA. Each value represents the average of 3 trials 
enumerating the total number of fluorescent bacteria bound to  200 host 
cells per trial as percent adherence of controls with co-incubation of 
legionellae with the saccharides listed in Table 3.1.
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Figure 3.8: Competitive inhibition of L pneumopNIa binding to guinea pig 
alveolar macrophages as measured by VBCC counts. Each value 
represents the average of 10 trials enumerating percent bacterial 
adherence of controls with co-incubation of legionellae with the 
saccharides listed in Table 3.1.
93







20 40 60 80 100 120
% Adherence of Controls
Figure 3.9: Competitive inhibition of L pneumopNIa binding to guinea pig 
alveolar macrophages as measured by IFA. Each value represents the 
average of 3 trials enumerating the total number of fluorescent bacteria 
bound to 200 host cells per trial as percent adherence of controls with co­
incubation of legionellae with the saccharides listed in Table 3.1.
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Figure 3.10: Surface membrane treatment of U-937 cells with agents in 
Table 3.2. Percent adherence of legionellae to U-937 cells as measured by 
VBCC counts. Each value represents the average of 10 trials.
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Figure 3.11: Surface membrane treatment of U-937 cells with agents in 
Table 3.2. Percent adherence of legionellae to U-937 cells as measured by 
IFA. Each value represents the average of 3 trials enumerating the total 
number of fluorescent bacteria bound to 200 cells per trial.
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X  Adherence of Controls
Figure 3.12: Surface membrane treatment of guinea pig alveolar 
macrophages with agents in Table 3.2. Percent adherence of legbnellae 
to guinea pig alveolar macrophages as measured by VBCC counts. Each 
value represents the average of 10 trials.
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Figure 3.13: Surface membrane treatment of guinea pig alveolar 
macrophages with agents in Table 3.2. Percent adherence of legionellae 
to  guinea pig alveolar macrophages as measured by IFA. Each value 
represents the average of 3 trials enumerating the total number of 
fluorescent bacteria bound to 200 cells per trial.
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Figure 3.14: Surface membrane treatment of L pneumophila with agents in 
Table 3.3. Percent adherence of legionellae to U-937 cells as measured by 
VBCC counts. Each value represents the average of 10 trials.
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Figure 3.15: Surface membrane treatment of L. pneumophila with agents in 
Table 3.3. Percent adherence of legionella to  U-937 cells as measured by 
IFA. Each value represents the average of 3 trials enumerating the total 
number of fluorescent bacteria bound to 200 host cells per trial.
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% Adherence of Controls
Figure 3.16: Surface membrane treatment of L pneumophila with agents in 
Table 3.3. Percent adherence of legionellae to guinea pig alveolar 
macrophages as measured by VBCC counts. Each value represents the 
average of 10 trials.
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% Adherence of Controls
Figure 3.17: Surface membrane treatment of L pneumophila with agents in 
Table 3.3. Percent adherence of legionella to guinea pig alveolar 
macrophages as measured by IFA. Each value represents the average of 
3 trials enumerating the total number of fluorescent bacteria bound to  200 
host cells per trial.
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3.5 Discussion and Conclusions
Legionellae are facultative intracellular pathogens. They have an 
intimate relationship with the cell-mediated immune (CMI) system of the 
host in that they primarily infect alveolar macrophages and mediating CMI 
is critical to  recovery. Legionella organisms can be controlled with 
antimicrobial therapy using antibiotics such as erythromycin, tetracycline, 
ciprofloxacin or rifampin, normally used in combination therapy (151,177). 
However, people often succumb to  Legionnaires' disease despite the 
implementation of appropriate and aggressive therapy soon after 
pneumonia is diagnosed (68). A fuller understanding of the interactions 
between this organism and the cells it infects is necessary for the 
development of alternative treatment regimes. In the absence of a toxic 
etiology for disease, binding is frequently the first event in bacterial infection 
which eventually leads to cell death or tissue invasion. This recognition 
process is especially necessary for diseases associated with facultative 
intracellular pathogens such as L. pneumophila (75,87,92,162). The binding 
process is complex and propably multi-factorial in form and organisms may 
possess several sets of adhesins which are used under different 
circumstances for binding to  alternative cell receptors (11). Moreover, to 
add to the already existing complexity o f measuring adherence, the 
methods used to assess attachment inevidably produce contradictory 
results making interpretation all the more difficult. In this study, the criterion 
used to  deem a treatment significant for modification of L pneumophila 
adherence was a 50% reduction of the experimental or treatment data
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compared with untreated controls.
Lectins are well known attachment factors for bacteria (133). For 
Legionnaires' disease to develop, the organism and cells of the undergo a 
recognition event which is followed by wash-resistant attachment (50,152). 
Several bacterial structures have been suggested as adhesins such as 
mucopolysaccharide capsules, lipoteichoic acid, various lectins, fimbriae, 
flagella, lipopolysaccharide and outer membrane proteins (11,40,49,84, 
132,133,188). Although the adhesins for many bacteria and their 
counterpart host cell receptors have been identified, few binding 
mechanisms have been described in detail (92,93,132). For L. 
pneumophila flagella, fimbriae, lipopolysaccharide and outer membrane 
proteins have been proposed as potential adhesins (149), but none has 
been directly implicated. However, it is clear that the characterization of 
the binding phenomenon of L pneumophila to host cells is central to  
elucidating the pathogenesis of this disease. Work by Gibson and Rodgers 
(75) demonstrated that L. pneumophila binds to various host cells in the 
absence of opsonins in a wash resistant manner (see Section 2 and this 
report). These studies demonstrated that the Legionnaires' disease 
bacterium bound to U-937 cells in the absence of either complement or 
specific antibody. In this study it was demonstrated that a MOI of 100 was 
appropriate for studies involving adherence of Legionella to 
macrophages. In addition, the preliminary characterization of the bacterial 
and host cell molecules involved in binding are described. This mechanism 
of bacterial attachment to host cells would appear to be a relatively
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U-937 or GAM cell Receptor 
Glycolipid
Figure 3.18: Schematic Representation of L pneumophila adhesin and host 
cell receptor for opsonin-independent attachment of this organism to U- 
937 or guinea pig alveolar macrophages.
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conserved process as many similarities exist between adhesin and 
receptor profiles for U-937, GAM and MRC-5 cells (75, unpublished 
observations).
To identify the process by which Legionella were taken-up, cells were 
pretreated with cytochalasin B, a potent inhibitor of microtubule formation 
(50). This was used to separate active invasion or phagocytic uptake from 
adherence. The cytochalasin treatment had no effect on attachment of L 
pneumophila to  U-937 or GAM cells. Complement-dependent uptake of L. 
pneumophila by phagocytes requires the preliminary deposition of the 
complement components C3b or C3bi on the surface of the MOMP of the 
organism. Following this coating process, opsonized organisms were taken- 
up via the complement receptors (CR) type 1 or CR type 3 on human 
monocytes (12). Preliminary data on the identification of the adhesin(s) and 
receptor(s) necessary for binding L pneumophila to  host cells in the 
absence of complement or serum suggested that this process occurred in 
a different manner. The use of U-937 and GAM cells for these experiments 
was justified by the observation that this pathogen infects the resident 
macrophages of the lung. The monosaccharides selected for competitive 
inhibition studies did not interfere with binding. Clearly, mono-, di, or 
oligosaccharides other than those examined may have blocked binding; 
however, the requirement to screen many thousands of compounds 
rendered this unfeasable. Subsequent studies examined the role of 
carbohydrates in attachment by oxidizing these compounds on bacterial 
or host cell surfaces. Indeed, treatment of L. pneumophila with surface
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modifying agents indicated that the adhesin was a complex structure 
containg protein, carbohydrate and possibly lipid. It is possible that the 
adhesin in question was the MOMP of Legionella; as is the case for opsonin- 
dependent binding. The lipopolysaccharide of L pneumophila is very 
closely associated with MOMP to the point where purified LPS is inevidably 
contaminated with MOMP and vice versa. LPS is an important structure for 
both the establishment of disease and as an activator of the immune 
system (119). Isolated LPS from various organisms has been shown to bind 
to human monocytes via several key structures including the CD 11/CD18 
Leu-CAM comple (a 80-kDa protein), the glycolipid CD 14 (a lectin-like 
molecule), as well as LPS binding proteins found in human serum (72,104, 
188, 189). LPS requires further examination in binding studies.
Receptor modification studies suggested that the proposed host cell 
receptor responsible for binding L. pneumophila was comprised of 
carbohydrate and lipid material but lacked protein and was possibly a 
glycolipid moiety. Wether this is identical to the previously described 
glycolipid CD 14 is not clear. However, it does seem clear that in the 
absence of complement the glycoprotein receptors CR1 and CR3 were 
not involved in binding L. pneumophila. The non-opsonin adhesin/receptor 
process outlined in Figure 3.17 may be an alternate even critical 
mechanism for Legionella-host cell attachment especially early in disease 
when inflamation and hence increased opsonin levels have not occurred 
(75, 152). This becomes of greater significance given the observations of 
Reynolds and Newbold (145) that the lung and secretions are almost
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devoid of the opsonins complement and IgM. Following Legionella- 
induced tissue destruction, the increase in opsonin concentration may well 
augment opsonin-mediated uptake and thus facilitate disease.
It was clear that metaperiodate oxidation and treatment with 
various lectins strongly inhibited L pneumopNIa attachment. Lectins are 
proteinaceous structures which possess the ability to recognize specified 
carbohydrate moieties. The type 1. Pap and S fimbriae often found in 
members of the Enterobacteriaceae frequently show lectin activity. 
Indeed, for these organisms fimbriae are believed to be central to 
attaching bacteria to sufaces (90,118,123,132). Type 1 fimbriae bind to o- 
mannose residues (1,133). Although, the major subunits vary widely from 
species to species the tip is a conserved structure across most type 1 
fimbriae of the Enterobacteriaceae (49). This structural organization is 
common among other fimbriae such as the Pap pili and S fimbriae that 
recognize a-Gal (l->4) (J-Gal and sialic acid containing glycoconjugates
(90,121). In these studies, D-mannose did not compete with L 
pneumophila for binding sites for U-937 or GAM cells. Although L 
pneumophila possess fimbriae, it seems that Type 1 fimbriae are not 
involved in opsonin-independent adherence described. In addition to 
these findings the use of galactose, N-acetyl neuraminic acid and 
neuraminidase failed to inhibit L pneumophila adhesion to these cells. The 
contradictory data from the competitive assays with mannose and N- 
acetyl-galactosamine, and the lectins Con A and WGA (these binding
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ligands for mannose and N-acetyl galactoseamine respectivly) may reflect 
steric phenomena involving lectin recognition of the appropriate 
saccharides in the proximity of the host cell receptor. Data from the 
metaperiodate oxidation of carbohydrates supported these suggestions.
It Is also possible that Legionella possess a myriad of attachment 
molecules and that the organism can modulate their expression as 
required. A comprehensive characterization of both adhesin and 
receptor will require their isolation and purification; however, these 
procedures are complex (11,60,74,165). Mucopolysaccharide capsules 
are important for the adherence of bacteria to oral tissue cavity (74), while 
Bacteroides fragilis possess polysaccharides which are potent mediators of 
abscess formation (175). Capsules have also been shown to decrease 
both antigenicity and decrease the phagocytotic expression of 
macrophages for encapsulated bacteria (125). Although data is 
conflicting, it would appear that Legionella do not produce a capsule 
(150). Studies are further complicated in that traditional laboratory batch 
growth procedures tend to select for organism populations not expressing 
adhesins. This is brought about because nutrients are present to excess 
and so there is no advantage for their expression. Variations in culture 
conditions for bacterial populations used in adherence study may produce 
widely divergent results.
Facultative intracellular bacterial pathogens such as L pneumophila, 
L. monocytogenies. M. tuberculosis, S. typhi and Y.pestis belong to this 
group of facultative intracellular pathogens and all have demonstrated
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fascinating strategies for infecting and surviving within host cells (60,83,75, 
125,166). Legionellosis has serious implications for the health of the nation 
especially given the spectacular outbreaks that occur from time to time. 
Antimicrobial intervention which is not preventitive, may not successfully 
eradicate the pathogen. In addition, resistant strains have been reported 
and organisms cannot be removed from the environment entierty. As a 
consequence alternatives to  conventional therapeutic regimes are 
required for to prevent severe cases of legionellosis among susceptible 
individuals. A vaccine to augment antibiotic therapy is required. 
Attachment to the alveolar macrophage is the first stage of Legionello- 
induced disease; therefore, it may serve as a potential attack site for 
vaccine research. A vaccine that is capable of interrupting or preventing 
this binding event may prove an efficacious addition to the clinical 
armarmentarium for the prevention of Legionnaires' disease.
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SECTION IV
ASSESSING THE ROLE OF COMPLEMENT RECEPTORS FOR ATTACHMENT OF 
LEGIONELLA PNEUMOPHILA TO U-937 CELLS.
(The work outlined in this Section has been published in abstract form: 
Gibson, III, F. C., and F. G. Rodgers. 1994. Role of complement receptors in 
non-opsonin mediated adherence of Legionella pneumophila to LI- 
937 cells. Abst. Gen. Meeting ASM. D-49: p 104.)
4.1 Abstract
In order to define the role of CR1, CR3 and CR4 in the opsonin- 
independent adherence process of legionellae to macrophages, a series 
of monoclonal antibodies to CR1 (CD 35), CR3 (CD 1 lb  + CD 18) and CR4 
(CD 1 lc  + CD 18) were used both individually and in combination to block 
these potential binding sites. These monoclonal antibodies either individually 
or in combination failed to inhibit the binding of L pneumophila to U-937 
cells as compared with untreated control cultures. It would seem that 
opsonin-independent attachment of L pneumophila to U-937 cells is 
mediated by host cell binding ligands other than CR components.
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4.2 Introduction
The nature of Legionella pneumophila attachment to host cells is 
poorly understood. Moreover, the mechanism by which intracellular 
pathogens infect host cells has been shown to  be critical for the 
establishment of infection. Initial investigations by Horwitz et al. (87) 
demonstrated that uptake of L pneumophila by human monocytes was 
mediated by the deposition of complement onto the MOMP of Legionella 
organisms. This complex is then bound to the complement receptors CR1 
and CR3 (12). In addition, the LPS of L. pneumophila has been shown to 
activate the classical complement cascade (119) and this observation 
supports the opsonin-dependent process of host cell infection. Work from 
our laboratory (76, and this reprot Section II) demonstrated that direct 
attachment of L. pneumophila to U-937 cells occurs independent of 
opsonins and that this process may be central to  the initiation of disease 
(75,76,91).
Cell mediated immunity (CMI) in conjunction with humoral support is 
critical to  the recovery from disease. Macrophages and 
polymorphonuclear leukocytes (PMNL) are the primary phagocytes 
involved in the eradication of these bacterial pathogens. The process by 
which these cells engulf and destroy bacteria is well documented; 
however, they fail to  function adequately when the host is challenged by 
the facultative intracellular pathogen, L. pneumophila. Normally, 
macrophages first engulf, internalize and process invading microorganisms 
before destroying them. In functional terms, the phagocytic cell appears
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to be an unattractive host for Legionella; despite this, Legionella have the 
ability to parasitize these cells. The processes by which these bacteria gain 
access to  host phagocytes and then evade their microbicidal activities are 
diverse. The successful activation of such processes directly affect the 
survival of either the organisms or of the host cells in the ensuing struggle for 
supremacy. Two groups of bacterial attachment mechanisms to 
phagocytes have been identified and these include opsonin-dependent 
and opsonin-independent processes. Opsonin-dependent mechanisms of 
microorganism uptake have been elaborated in greater detail then those 
binding systems which occur via opsonin-independent processes. 
Opsoninization involves two processes in which organisms pre-coated with 
specific antibody bind to phagocytic cells usually through Fc receptors.
This binding induces cellular production of reactive oxygen metabolites 
(187) which are critical to the breakdown of foreign material. In contrast, 
those pathogens that bind to complement receptors (CR1 or CR3) via 
complement do not elicit an oxidative burst (182,187). Organisms which 
use CR1 and CR3 for entry into the intracellular matrix of the host cell are 
afforded a potentially safer route for intracellular infection than those 
entering via Fc receptors.
Recently, the heterodimeric fc integrin family of leukocyte cell
surface adhesion molecules have been shown to be important for binding 
prokaryotic and eukaryotic pathogens, as well as bacterial surface- 
expressed components to host cells (4,12,162). This family of leukocyte
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receptors includes LFA-1, CR3, and CR4 (p i 50,95), of which CR3 and CR4 
are important mediators for binding the third component of complement 
(C3) as well as for mounting a functional immune response (157,158,159). 
As a group, these molecules comprise an a (CD1 la , b, c) and p (CD 18)
subunit with the p subunit conserved by all members of the integrin group
(167). The human histiocytic lymphoma, U-937 cell line, has a receptor 
profile similar to that of both monocytes (pre-phorbol ester activation) and 
macrophages (post activation) (161). Known opsonin receptors on the 
surface of activated U-937 cells include, fibronectin-binding protein, CR1, 
CR3, CR4 and Fc receptor for IgG (158,161, 162,167). The profile and 
distributions of these receptors is similar to that for human alveolar 
macrophages and make this cell an attractive model for the study of 
direct attachment of L pneumophila via complement receptors (12).
4.3 Materials and Methods 
4.3.1 Bacterial Growth and Maintenance
L pneumophila strain Nottingham N7 was grown and maintained as 
previously described (Section 2.3.1).
4.3.2 U-937 Cell Cultivation
U-937 cells were grown and phorbol ester treated as previously 
described (Section 2.3.2).
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a incubation conditions were 60 min at 37°C for all treatments
Clones YFC 118.3, El 1, and Sp2/0-Agl4 are of mouse origin and were 
obtained from Serotec International, Indianapolis, IN. Monoclonal 
antibodies from clones M l/70 .15.11.5 and M18/2a. 12.7 were rat anti­
mouse and possessed cross-reactivity with human epitopes. These were 
kindly donated by Dr. A. Sloan.
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Complement Receptors CR1, CR3 and CR4
C3bi
CD lib
CRT CR3* CR4 
(pi 50.95)
Figure 4.1: Complement receptors responsible for binding C3b 
and C3bi. * Denotes those receptors responsible for opsonin- 
dependent attachment of L. pneumophila to host cells. Adapted 
from Springer 1984.
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4.3.3 Receptor Inhibition Studies Using Specific Monoclonal Antibodies
U-937 cells grown on coverslips in 6-well cell culture plates previously 
treated with PM A were washed 5 times with HBSS to remove RPMI-1640 
and serum components (Appendix 1). The cells were resuspended in fresh 
HBSS and host cell Fc receptors were blocked by incubation at 37°C for 1 h 
with a non-specific rabbit antisera (generated in goat) used at a 
concentration of 100 ng/ml (Table 4.1). Following three washes to  remove 
unbound globulin, monoclonal antibodies specific for CR1, the a and p
components of CR3 and the a and p subunits of CR4 were added
individually as well as in combination to blockreceptor activity on U-937 
cells. The monoclonal antibodies used to block CR1 were of mouse origin 
and were directed against human epitopes. The CD 1 lb , CD 1 lc  and CD 
18 monomers of CR3 and CR4 on U-937 cells were either rat anti-mouse, 
mouse anti-human or rat anti-human in origin Gable 4.1). The rat anti-mouse 
sera were specific for human CD 1 lb  and CD 18 glycoproteins and it is 
known that these monoclonal antibodies recognize identical moieties 
conserved between human and murine systems. Treated cell cultures 
were incubated for lh  at 37°C, after which unbound antiserum was 
removed by washing three times with HBSS. L. pneumophila were added to 
these monoclonal antibody treated U-937 cells at a MOI of 100 in HBSS. 
Cultures were then incubated for lh  at 37°C, washed three times with HBSS 
and assayed by VBCC counts.
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AA Results
The treatment of U-937 cells with goat anti-rabbit IgG facilitated 
recognition of the monoclonal antibodies each to  the appropriate ligand 
and prevent loss of monoclonal activity to Fc receptors. This pretreatment 
was not inhibitory to the binding of L pneumopNIa (Fig. 4.2).
Phorbol ester treated U-937 cells express CR1. CR3 and CR4 (161). 
When added to U-937 cell cultures monoclonal antibody to  the human CR1 
(CD 35) did not inhibit the binding of the organism to U-937 cells (Fig. 4.2). 
Two separate sets of monoclonal antibodies were used to block CR3 
(Table 4.2) the major structure responsible for uptake of the Legionnaires' 
disease bacterium in the presence of complement. Data generated from 
these antibody blocking studies indicated that CR3 was not involved in 
organism binding. No inhibition of bacterial binding was recorded using 
these levels of monoclonal antibodies (Fig. 4.2).
Although, CR4 is weakly expressed on alveolar macrophages and U- 
937 cells it is structurally analogous to CR3 and is a potent receptor for C3bi 
(162). To neutralize the CR4 receptor monoclonal antibodies directed to 
human CD 1 lc  and CD 18 (Table 4.1) were used separately or in 
combination to block either the individual subunits or the receptor 
complex. These antibodies failed to neutralize the binding of L 
pneumophila to U-937 cells. It was clear that CR1, CR3 and CR4 and their 
substituant sub-units did not function as receptors for L. pneumophila in 
opsonin-independent adherence (Fig. 4.2).
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CR1, CR3 end CR4 VBCCC
Figure 4.2: Monoclonal antibody blocking of CR1 (CD 35), CR3 (CD 18 
and/or CD 1 lb ) and CR4 (CD 18 and/or CD 1 lc ) on the surface of U-937 
cells for inhibition of L. pneumophila-U-937 cell binding as measured by 
VBCC counts. Fc receptors were inactivated using a goat anti-rabbit 
antiserum prior to monoclonal antibody incubations. Each plotted data set 
is a mean of three trials.
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4.5 Discussion and Conclusions
Bacterial attachment to host cells is the first interaction of a 
pathogen with the host. This adherence phenomenon is an essential step in 
intracellular infection, whether for phagocytic or other cells (11,165). it 
would appear that the mechanisms used by phagocytes to take-up 
intracellular pathogens profoundly influences the development of cellular 
infection (11, 178,182,188).
L pneumophila has been shown to infect an extensive array of cells 
including amoebae, epithelial cells, fibroblasts, macrophages and 
monocytes (59, 75,87,94, 111,122, 134, 152). In opsonin-mediated 
adherence, the fragments C3b and C3bi of the complement system coat 
the organism prior to binding of legionellae to the surfaces of monocytes 
via CR3 and to  a lesser extent CR1.
Recently, opsonin-independent binding of this organism to U-937 cells 
has been reported (75,76,91,152, and Sections 2 and 3 of this report). 
Preliminary investigations to characterize receptor structures have proved 
inconclusive but suggest a glycolipid moiety as the adherence receptor for 
MRC-5, U-937 and GAM cells. The monoclonal antiboby blocking studies 
offer some confermation of these findings in that the glycoprotein 
receptors CR1, CR3 and CR4 were not involved in the direct binding of L. 
pneumophila to  host cells.
Two of the three complement receptors CR3 and CR4 (p i 50.95) 
responsible for binding various C3 components on the surface of 
phagocytes are integrins while CR1 is not. These heterodimeric integrins
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which bind C3bi consist of a unique a subunit and a common p subunit. The
CR3 receptor is responsible for binding and uptake of complement coated 
legionellae (12,162).
Infection of U-937 cells in the absence of complement was 
achieved by infecting these cells with legionellae in HBSS. The role of CR 
molecules during complement-independent adherence of L pneumopNIa 
was assessed using a series of monoclonal antibodies. The CR1 receptor 
was shown to  take-up legionellae in an indirect fashion, while CR3 directly 
bound L. pneumophila to  monocytes. As all the monoclonal antibodies 
used in this study were of IgG origin, it was necessary to block the Fc 
receptor of the U-937 cells prior to the addition of monoclonal antibodies 
using goat anti-rabbit serum to U-937 cells. Binding of the organism was 
unaffected by the presence of this antibody at the host cell surface 
indicating that as expected, as expected the Fc receptor was involved in 
opsonin-independent binding.
The present data indicated that the CR molecules (CD 35 of CR1; CD 
1 lb  and CD 18 of CR3; CD 1 lc  and CD 18 of CR4) were not involved for 
either attachment or uptake. As described in Section 3, the chemical 
nature of host cell receptors indicated that glycolipids (carbohydrate 
and/or lipid), rather than proteins or glycoprotein structures such as CR1, 
CR3 and CR4 were involved in the binding legionellae by this ‘ alternate' 
non-complement mechanism. In addition, the bacterial adhesin would 
appear to be protein or glycoprotein-like in nature (Section 2).
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During the first recognition of this organism by alveolar macrophages 
and prior to the initiation of disease, the environment of the lung and the 
alveoli contains few opsonins as shown by analysis of lavage fluids (145). In 
the present model, it is suggested that CR components are not the primary 
host cell receptors to which L. pneumophila bind in the earliest phases of 
disease. Indeed, it would seem likely that this non-opsonic uptake would be 
of grater importance until cellular damage has occurred and opsonin 
levels increase in the lungs. Whether a given cell can take up Legionella 
organisms by a non-opsonic process simultaneously with opsonin-mediated 
mechanisms is not known. However, unlike studies in which complement 
components are excluded and therefore only opsonin-independent 
processes are assessed, experiments conducted in the presence of 
complement do not exclude the possibility of opsonin-independent uptake 
from occurring also. Indeed, it seems probable that in experiments 
conducted with serum or complement present, organisms may enter the 
cell by both processes. Whether the intracellular fate of the organism 
differs under these circumstances is unknown, but it may be speculated 
that since a full cycle of cell infection occurs in the absence of opsonins 
that opsonin-independent uptake may be the major route leading to 





Legionella pneumophila is a facultative intracellular bacterial 
pathogen responsible for the potentially fatal illness Legionnaires' disease. 
This organism has previously been shown to infect a wide variety o f host 
cells including amoebae, epithelial cells, fibroblasts, macrophages and 
monocytes (59,94,99, 122, 134, 147, 187). However, following exposure 
and inhalation by humans, legionellae preferentially infect alveolar 
macrophages in the lung (183). The processes by which L. pneumophila 
infects macrophages and monocytes has been shown to be dependent 
on the deposition of complement on the MOMP of these organisms and 
the opsonized bacteria are taken-up via CR1 and CR3 (12). In the present 
work an alternative process for Legionella attachment to host cells have 
been identified and the molecules involved in adherence has been 
partially characterized. This process occurred in a fashion independent of 
complement, opsonization or complement receptors. Opsonin- 
independent attachment occurred independent of cytochalasin 
treatment of host cells and wash-resistant, suggesting that this type of 
binding occurred independent of phagocytosis and the MIP protein and 
that attachment has proceeded beyond the weak
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erelectrostatic or Van der Waals forces responsible for early host cell- 
pathogen interaction. This attachment mechanism led to complete 
replication and release of organisms in the macrophage-like U-937 cell and 
was similar in to other published studies on the ultrastructural events and 
multiplication kinetics of L. pneumophila in other host cells (75, 111, 152).
These studies describe an adhesive structure for L. pneumopNIa that 
was responsible for direct cell infection and indicated that the molecule 
was a complex of protein and carbohydrate and/or lipid moieties and 
which possessed lectin-like activities. The host-cell receptor for binding L. 
pneumophila was comprised of carbohydrate and lipid in the absence of 
proteins. As the complement receptors CR1 and CR3 are glycoproteins on 
macrophage surface membranes and are believed to be solely 
responsible for the docking L pneumophila, carbohydrate oxidation and 
proteolytic modification should inhibit organism binding. As this was not the 
case it suggested receptor structure other than complement receptors. 
Monoclonal antibodies specific for CR1, CR3, CR4 and their subunits 
demonstrated that these cell-expressed components were not involved in 
opsonin-independent binding to macrophages. These antibodies did not 
inhibit L. pneumophila binding to U-937 cells.
It is postulated that such an alternative mechanism of binding is 
central to the initial establishment of cell infection in the human lung.
Clinical evidence to support this suggestion indicates that the lung are 
essentially devoid of complement (145). If disease is to become 
established in the lung non-opsonin-mediated processes would need to
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occur. The identification of alternative attachment mechanisms and the 
isolation and purification of the molecules responsible for attachment of L 
pneumophila by macrophages may prove useful for the production of 
vaccines. Such vaccines would be of major advantage for augmenting 
current antimicrobial strategies especially since antibiotics unlike vaccines 
neither prevent infection nor reduce the mortality arising from 
Legionnaires' disease.
5.2 Future Studies
Host infection with L. pneumophila is a complex series of events and 
expression of bacterial virulence factors as well as the status of the immune 
system of the host are central to the initiation and development of this 
disease. Several interesting lines of inquiry emerge from the present study 
and these merit further investigation:
1- A panel of monoclonal antibodies should be raised against 
Legionella surface proteins to challenge the organism-host cell binding 
event to define those structures as potential adhesins.
2- Identification of the genes responsible for the expression of 
adherence factors on L. pneumophila should be conducted. The 
generation of isogenic strains of L. pneumophila that do not express the 
adhesin should by undertaken and these mutant strains should be tested 
for binding potential.
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3- The role of complement receptors in the establishment of disease 
requires clarification. Mutants of L. pneumophila carying different 
genotypic markers but possessing similar binding and intracellular growth 
characteristics as parent strains should be developed and used to 
differentiate which receptors are preferentially used for uptake by this 
organism. In such syudies, one genotype could be added to cells without 
opsonins and the different genotype could be added with complement 
and serum and the progeny assayed to determine which replicated 
intracellularly. These studies may resolve whether organisms takervup by 
complement-mediated processes are destroyed or eventually lead to cell 
infection.
4- The role of cytokines and other immune function modulators 
should be assessed for their part in the bacterial infectious process at the 
cellular and molecular levels. It may prove feasible for those with inhibitory 
effects to be used in association with conventional therapy to augment 
antibiotic therapy.
5- The role of B and T cells in immunity is unclear. Data on the 
recognition events by T cells as well as the influence of specific antibody in 
long term immunity is required. These studies may profoundly influence 
vaccine development.
6- The interaction of legionellae with environmental amoebae
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should be investigated to determine whether the binding processes 
characterized in the present study are conserved in nature. Such studies 
would assist with our understanding of human disease, as well as survival of 
the organism in the supernatant.
7- The part played by the major secretory protein of L. pneumopNIa, 
the zinc metaloprotease, as well as, other exotoxic products produced by 
the organism should be determined for the part these compounds play in 
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APPENDICES
Appendix 1; Biological Studies
A. Bacterial Cultivation
1.1. Storage of Bacterial Cultures
Legionella pneumophila serogroup 1 strain N7 is a virulent strain of 
this organism. Organisms were stored at -70°C throughout this study. 
Thawed alliquots grown on buffered charcoal yeast extract agar (BCYE-a)
were periodically assessed for virulence using the fertile hens egg model 
(Tzianabos).
1.2. De-ionized water
All water used in these studies were obtained from a MillhQ filtration 
system (Millipore). Water was collected from the outflow port after ten 
megaohm resistivity was reached. The water was passed through a 0.2 urn 
sterile filter and stored at 4°C in the dark.
1.3. Buffered Charcoal Yeast Extract Agar (BCYE-a)
The preferred agar for the cultivation of Legionella is BCYE-a agar. 
This media was purchased in dehydrated form from Becton Dickinson
147
(Cockeyesville, MD) and is resuspended in Milli-Q water. The formulation 
ofthis agar is as follows:
To 800 ml of fresh Milli-Q water 38.3g of BCYE-a was added and
mixed until dissolved. A volume of ION KOH was added dropwise to the 
agar solution to adjust the pH to 6.9. The final volume was adjusted to 1 liter 
by adding Milli-Q water. The agar was sterilized by autoclave using 121°C 
at 12 psi for 20 min and the media was allowed to cool to 52°C. 4 ml of a 
10% L-cysteine in Milli-Q water was added to each liter, was evenly 
distributed throughout the media and plates were poured. After the plates 
cooled, they were placed in an incubator at 37°C overnight to check for 
sterility and were stored at 4°C in a sealable plastic bag containing moist 
paper towels until needed.
1.4. Buffered Yeast Extract Broth (BYE-a)
BYEa- broth was used in this study to grow legionellae from plate
cultures. This media was the standard broth for L. pneumophila cultivation 
























These components were added in sequence to 800 ml of Milli-Q 
water. The broth was then adjusted to pH of 6.9 with the dropwise addition 
of 10N KOH and the total volume was adjusted to 1 liter with fresh Milli-Q 
water. The BYE-a broth was filtered through a 0.45 nm filter and then
through a sterile 0.22 nm filter for final sterilization. 4 ml of a 10% L-cysteine 
solution was added per liter and this was alliquoted into 5 ml batches and 
tested for sterility in a similar manner to BCYE-a agar.
1.5. Phosphate Buffered Saline (PBS)
This isotonic buffer was used in various studies for washing bacteria 
as well as host cells and was made in Milli-Q water. The formulation used 
was:
PBS was adjusted to a pH of 7.2 by addition of 10N NaOH and was 
sterilized by autoclaving. Solutions were stored at 4°C in 500 ml batches in 












1 g of peptone was disotved in 100 ml of Milli-Q water. The solution 
was sterilized by autoclaving and was then aliquoted in 0.9 ml volumes with 
a Cornwall syringe into sterilized standard type dilution blank test tubes. 
These 0.9 ml dilution blanks were stored overnight at 4°C prior to use.
B. Cell Culture
1.7. De-tonized water
See appendix 1.2 above.
1.8. Hank's Balanced Salt Solution (HBSS)
Sterile batches of 500ml lOx concentrated HBSS with supplemented 
phenol red was purchased from Sigma (Sigma, St. Louis MO). To 450 ml of 
sterile Milli-Q water, 50 ml of sterile HBSS was added. The pH of this solution 
was adjusted to 7.2 with sterile 1N Na2HC0 3 . These batches were tested 
for sterility by placing the prepared bottles at 37°C for 24 h. Furthermore, a 
0.1 ml sample of HBSS was plated on both nutrient and blood agar and 
these plates were checked for sterility following 24 h incubation at 37°C. 
Sterile HBSS was stored at 4°C until needed.
1.9. Glutamine
L-glutamine was purchased in sterile 100 ml batches at a 
concentration of 200 mM in water (Sigma) and was stored at -20°C until 
needed.
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1.10. Fetal Bovine Serum
Sterile fetal bovine serum (Hybrimax) was purchased from Sigma in 
500 ml batches. The contents of each bottle was thawed and alliquoted 
into 25 ml batches in sterile 50 ml conical tubes and stored a t -20°C until 
needed.
1.12. Sodium bicarbonate
A 7.5% sodium bicarbonate solution was prepared by adding 7.5 g 
Na2HC03 to 100 ml fresh Milli-Q water. This was filter sterilized by positive 
pressure filtration through a 0.22 jim membrane filter into a sterile 100 ml 
dilution bottle and was stored at 4°C until needed.
1.12. Sodium Hydroxide
A IN NaOH was prepared by adding 4g NaOH pellets to 100ml 
distilled water and this solution was sterilized by autoclaving.
1.13. RPMI-1640
U-937 cells and guinea pig alveolar macrophages were cultivated in 
RPMI-1640 without antibiotics. Basal RPMI-1640 cell culture media 
containing phenol red was purchased as lOx stock solutions in 500 ml 
alliquots from Sigma and were stored at -20°C. For culture, the basal 







7.5% Sodium bicarbonate 5 ml
The RPMI-1640 medium was adjusted to pH 7.2 with NaOH. Samples 
of each media were batch tested for sterility by adding 0.1 ml alliquots of 
cell culture media to  both nutrient and blood agar plates. These plates 
were incubated overnight at 37°C and examined the following morning. 
Sterile media was stored at 4°C.
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Appendix 2; Electron Microscopy
A. Transmission Electron Microscopy
2.1. Grids
Copper grids of 400 mesh were purchased from Electron 
Microscopy Supplies (EMS) and were used for all studies.
2.2. Collodion
A stock solution collodion was purchased as 10% nitrocellulose 
dissolved in EM grade amyl acetate. This solution was diluted to 1% with EM 
grade amyl acetate and stored at room temperature in the dark.
2.3. Collodion Coating of Grids
3 drops of collodion solution were dropped onto the surface of a 
standard petri dish containing 20 ml Milli-Q water. The lid was placed over 
the top of the dish in canted fashion to prevent dust accumulation on the 
films and to permit evaporation of amyl acetate resulting in the production 
of ultra-thin collodion films. Copper grids were place face down on the 
collodion films using forceps and were collected using dust-free parafilm. 
Collected copper grids were allowed to dry at room temperature 
overnight prior to use.
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2.4. Cacodylate buffer
0.1M cacodylate buffer (Electron Microscopy Sciences) was made 
by adding 21.4 g sodium cacodylate-trihydrate to 1 L Milli-Q water. Then 10 
mM MgSOj was added to this solution. Cacodylate buffer was adjusted to 
pH 7.4 and stored in the dark at 4°C until needed.
2.5. Glutaraldehyde
EM grade glutaraldehyde was purchased from EMS as a 50% solution 
and was stored refrigerated, in the dark. Prior to TEM and SEM studies, 
glutaraldehyde was diluted to 3% in cacodylate buffer and was used for 
specimen fixation. Glutaraldehyde was used in a fume hood.
2.6. Osmium Tetroxide
Osmium tetroxide was purchased as a solid from EMS in glass vials in 
vacuo and were stored at 4°C. Working strength osmium tetroxide was 
prepared by placing the contents of a 1 g vial in 50 ml cacodylate buffer 
to make a 2% (w/v) stock solution. Equal volumes of 2% osmium solution 
and cacodylate buffer were placed over each sample and they were 
fixed overnight at room temperature. OSO4 was used in a fume hood and 
waste was disposed of in proper fashion according to  University policy.
2.7. Graded Ethanol Series
Absolute ethanol was diluted with cacodylate buffer to create a 
series of 50%, 70%, 75%, 90% and 95% ethanol. Each dilution was stored in
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sealed bottles and was kept at room temperature.
2.8. Propylene Oxide
Propylene oxide was purchased from EMS ready for use and was 
stored tightly stoppered in a cool dark place.
2.9. Resins
An epon-arlydite resin mixture was used to embed specimens for thin 
sectioning. All resin components were purchased from EMS and were 
stored at room temperature in the dark. The recipe and proportions used 




Dodecyl succinic anhydride 3 parts
Dibutyl phthalate (plasticiser) 0.8 parts
DMP-30 (accelerator) 0.4 parts
All resins were measured using plastic tri-pour beakers or plastic 
syringes. The resins were added in sequence to a glass bottle (except for 
the DMP-30) and were shaken vigorously for 10-15 min. The resin mixture 
was divided into 4 equal parts and was complete by the addition of DMP- 
30 at the appropriate concentration (see TEM procedure 2.10). The 
complete resin was then shaken for an additional 3 min to facilitate even 
distribution of DMP-30. All manipulations were performed in a fume hood.
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2.10. TEM Procedure
Cell cultures in T-75crr>2 flasks either infected with Legionella or non­
infected were fixed in situ with 3% (w/v) glutaraldehyde for 2 h. Samples 
were not allowed to  dry at any stage of the embedding process. Following 
fixation, cells were washed 10 times with cacodylate buffer and were 
scraped from the surface of the flask using a silicon rubber-coated pipette. 
The samples were lightly pelleted in an eppendorf tube and supernatants 
were decanted. Samples were then embedded in 2% nobel agar and 
fixed overnight in 1% (w/v) osmium tetroxide.
Washed, osmicated samplest were dehydrated using a graded 
ethanol series of 50%, 70%, 75%, 90%, 95% at 5 min each to reach absolute 
ethanol followed by two changes of 10 min each in absolute ethanol. The 
samples were further dehydrated in propylene oxide with 2 changes of 10 
min each. Following the preparation of the epon-aryldite resin mixture, a 
gradient resin series was made to facilitate impregnation of specimens.
The samples were placed in each step of a gradient consisting of 1 part 
resin and 2 parts propylene oxide for 1 h and then 2 parts resin resin and 1 
part propylene oxide for 1 h. Samples were then placed in 100% resin and 
then into 100% degassed resin for 1 h each.
Agar embedded, resin impregnated samples were placed at the 
bottom of a beam capsule, one specimen per capsule, using a wooden 
dowel trimmed to form a spatula-like end. In addition, paper labels marked 
with lead pencil were placed into each of the appropriate capsules. 
Samples were covered with complete degassed resin and were
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polymerized in a 60°C oven for 24 h. Blocks were removed from capsules 
after 48 h and allowed to fully harden. Blocks were trimmed and ultra-thin 
60-90 nm section cut with a LKB uitratome III ultramicrotome using a Diatom 
diamond knife. Sections were collected on 400 mesh copper grids. 
Sections were stained with uranyl acetate for 1 min., washed with 20 ml of 
boiled, cooled Milli-Q water and the stained with lead citrate for 30 sec. 
followed by 50 ml rinsing with boiled, cooled milli-Q water. After drying, 
stained grids were observed and photographed on a Hitachi scanning- 
transmission electron microscope in the transmission mode at an 
accelerating voltage of 75kV.
2.11. Uranyl acetate staining
Uranyl acetate was purchased from EMS and was stored at room 
temperature in the dark. A 5% stain solution was made by placing 1 g 
uranyl acetate in 20 ml sterile filtered Milli-Q water. After allowing overnight 
to dissolve, the stain was filtered through a 0.45 nm filter into a clean, dry, 
screw-top tube and was stored at room temperature covered with 
aluminum foil.
2.12. Lead citrate staining
A sodium hydroxide pellet was dissolved In 15 ml boiled, cooled Millh 
Q water. A 0.5% lead citrate solution was made by placing 0.1 g lead 
citrate into the 15 ml solution and this was followed by the addition of 10 ml 
boiled, cooled Milli-Q water. After sitting overnight to fully dissolve, 1 ml
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alliquots were centrifuged at 12,400 x g for 20 min and supernatants were 
stored at room temperature, in the dark, wraped in foil until needed.
B. Scanning Electron Microscopy
2.13 Hexamethyldisalizane (HMDS)
HMDS was purchased from EMS in ready to use form. This highly 
volatile substance was stored tightly stoppered and stored in a cool dark 
place.
2.14 SEM Procedure
Samples in 6 well plates on coverslips were fixed with 3% 
glutaraldehyde for 2 h. Following fixation, samples were washed 
extensively with PBS and dried in a graded ethanol series in situ (50%, 70%, 
75%, 90%, 95% and 100%) in similar fashion to TEM studies (Appendix 2.10). 
Specimens on coverslips were dried from hexamethyldisalazane (HMDS) 
were fixed on the top of a carbon coated stub and were stored at room 
temperature in a desiccated environment. The coverslips were placed in 
a sputter coater and were coated with 20 nm gold-palladium using a 
target to specimen distance of 5 cm and 15 mA for 4 min. Specimens 
were placed in an AMR-1000 scanning electron microscope with an 
accelerating voltage of 60kV.
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Appendix 3: Guinea Pla Care and Alveolar Macrophage Collection
All animal procedures were conducted according to NIH guidelines 
as governed by the University of New Hampshire, Animal Care and Use 
Committee. Experiments were performed under the licence 930803 and 
its predicessors issued to Dr. Frank G. Rodgers.
3.1. Animal Specifications
Hartley outbread guinea pigs (either sex) of 600-650 g were 
purchased from Charles River Laboratory. The animals were shipped in 
one day in filtered cartons. Upon arrival, each animal was checked for 
general appearance, sexed, weighed, fed as needed and placed into a 
separate cage to  stablize.
3.2. Animal Living Conditions
All cages conformed to Animal Care and Use Committee guidelines 
for size. In addition, each cage contained a generous amount of wood 
chips which were changed on an animal to animal need basis.
3.3. Food and Water




Each animal was weighed and sacrificed prior to collection of 
alveolar macrophages with an intraperitoneal injection of nembutal 
(sodium pentobarbitol). Animals were then bleed by laceration of the 
dorsal aorta and descending vena cava to limit the amount of blood in 
macrophage cultures. Following collection of macrophages, each animal 
was delivered to UNH animal facilities for proper disposal.
3.5. Collection of Alveolar Macrophages
Following exsanguination, the trachea was exposed and clamped- 
off using a hemostat to prevent descending contamination of cultures and 
to restrict fluid motion in the respiratory tract. A 10 ml syringe with an 15- 
gauge needle containing ice-cold HBSS (pH 7.2) was inserted into the 
trachea and the contents of the needle was slowly expelled into the lungs. 
Following a 1-2 min incubation, the fluid was removed by aspiration with the 
same syringe. This procedure was repeated a total of four times per 
animal. Collected samples were placed on ice until they were processed.
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